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Shunt catheter obstruction due to the foreign body host response is a serious 
problem in the treatment of hydrocephalus.    Our goal was to reduce inflammatory cell 
adhesion on silicone catheters in an effort to limit shunt obstruction.    We investigated 
chemical and mechanical cues that may influence macrophage and astrocyte adhesion, 
and using this knowledge, examined pertinent catheter modifications.     A novel in vitro 
bioreactor, capable of measuring dependencies between macrophage and astrocyte 
adhesion, intracranial flow rate, pressure, pulsation frequency, and protein concentration, 
was developed and tested.   Results demonstrated that a combination of chemical cues 
(particularly surface chemistry) and mechanical cues (particularly shear stress) influenced 
macrophage and astrocyte attachment to shunt catheters.    The surface chemistry of the 
catheter was modified using long term coatings with anti-inflammatory capabilities 
including poly(ethylene) glycol and N-acetyl-L-cysteine, both of which significantly 
inhibited macrophage and astrocyte adhesion when tested in the bioreactor.    
Additionally,  the shear stress through ventricular catheter drainage holes was 
manipulated by changing the diameter of these openings.    Data generally suggested that 
macrophage and astrocyte adhesion decreases with increasing hole size.    Two barriers 
were overcome in this research: (1) the development of an in vitro system capable of 
testing catheter constructs in a method superior to standard static in vitro culturing; (2) 
significant surface and architecture modifications that inhibit inflammatory cell adhesion 
  
which could be used in future studies to inhibit inflammatory-derived obstruction.    
Together, the implementation of this system and the modifications to current catheter 
design will help answer questions of how and why catheters fail. 
iv 
  





“The treatment of hydrocephalus in infancy remains one of the most unsatisfactory and 
discouraging problems the neurological surgeon is called upon to treat.   Penfield’s 
statement made in 1935 that ‘all surgeons who continue to face the hydrocephalus problem 
require the support of fortified optimism’, is just as pertinent today.”       
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1.1.1 Clinical aspects 
 Hydrocephalus, an imbalance between cerebrospinal fluid (CSF) production and 
absorption, is a chronic disorder caused by impairment to the normal fluid pathway in the 
cranial cavity and spine.   Genetic malformations, meningitis, subarachnoid hemorrhage, 
stroke, trauma, tumors, or unknown reasons can restrict or completely block CSF outflow 
within the ventricles (obstructive or intraventricular hydrocephalus) or the subarachnoid 
space (SAS, communicating or extraventricular hydrocephalus).   This impairment in 
CSF outflow often causes elevated  intracranial pressure (ICP) because the CSF 
production rate exceeds the volume of the ventricles and subarachnoid space by 2-3 times 
in a normal state  [1].   The brain responds to ventriculomegaly with compensatory 
reactions such as partial CSF absorption into interstitial spaces to create edematous tissue 
and/or by decreasing the rate of CSF production, but in many cases these mechanisms are 
not capable of controlling ICP, and thus periventricular regions of the brain (especially 
the cerebral cortex) become compressed and distorted, and a multitude of secondary 
injury mechanisms are initiated [2].   If untreated, hydrocephalus usually causes serious 






spasticity, visual system impairments, reproductive dysfunction, and often death [3].   
The incidence of hydrocephalus is about 1 in 500 people, but the prevalence of 
hydrocephalus is constantly increasing.   In Sweden, Fernell and colleagues have shown 
that these increases in prevalence have caused the percentage of patients with 
neurological deficits to rise as much as 78% [4].    
 
 
1.1.2 Anatomy most pertinent to hydrocephalus 
 The cerebral ventricular system consists of the lateral, third, and fourth ventricles 
with a total volume of approximately 22.4 mL in adult humans [5].   The lateral ventricles 
are the largest compartments of the ventricular system.  They form two C-shaped arcs, 
are lateral to the midline, and are each composed of an anterior frontal horn, an 
intermediate body, a posterior occipital horn, and an inferior temporal horn.   The midline 
third ventricle separates the two thalami.   The fourth ventricle narrows to the obex where 
communication to the cisterna magna and the spinal cord occurs.   The lateral ventricles 
and the third ventricle communicate through two foramina of Monro, the third and the 
fourth through the cerebral aqueduct (also known as the aqueduct of Sylvius), and the 
fourth and cisterna magna through the paired foramina of Luschka and the midline 
foramen of Magendie.   Of all the communication pathways, the cerebral aqueduct has 
the smallest diameter with a cross section measuring 0.1 to 1.0 mm2 at its most restrictive 
point [6].   Because of the small width of the cerebral aqueduct, pathologically it is a 





 The choroid plexus is a tissue consisting of choroidal epithelium, blood vessels, 
and interstitial connective tissue found on the floor of the lateral and fourth ventricles and 
on the roof of the third ventricle [5].   CSF is produced by the parenchyma (30%) along 
perivascular spaces and axon tracts [7] and by the choroid plexus (70%) by actively and 
passively transporting filtrate of arterial blood from the anterior and posterior choroidal 
arteries [8].   Following production, CSF flows slowly through the ventricular system, 
exits the fourth ventricle to gain access to the subarachnoid space, and finally is absorbed 
by the vascular system through the cranial dural venous sinuses, the veins adjacent to the 
spinal nerves, and the lymphatics surrounding some cranial nerves [9-10] (Figure 1).   
Although there is no direct way to measure CSF production rate, it can be interpreted 
through MRI studies or through ventricular tapping.    As calculated using MRI, the 
average normal CSF production rate is expected to be about 0.3-0.36 mL/min  [11].   At 
this rate, the volume of CSF exceeds the volume of the ventricular system in about 1.25 
hours. 
 CSF serves as a protective cushion around the brain, nourishes the brain with 
glucose, essential amino acids, essential proteins, and vitamins, may serve as a pathway 
for diffusible neuromodulators and trophic substances, and provides a conduit in which 
waste can be excreted [12-14].   Depending on the integrity of the blood-brain barrier 
(BBB) and the pathological state, the total CSF protein concentration is approximately 
20-40 mg/dl and from highest to lowest concentration (mg/dl) include albumin (11.5-
19.5), immunoglobulin G (IgG, 0.7-2.0), transferrin (0.3-1.2), α1-antitrypsin (0.4-1.0), α2-





acid glycoprotein (0.1-0.25), haptoglobin (0.075-0.4), ceruloplasmin (0.07-1.0), and 
fibrinogen (0.065).   The relatively low concentration of protein in CSF compared to 




1.1.3 Dynamics of hydrocephalus 
 CSF dynamics are influenced by CSF production, circulation, and drainage.   The 
production rate of CSF under normal conditions is constant but the average patient with 
chronic hydrocephalus has a decreased production rate of 0.25 ml/min [15-16].   
Normally, CSF circulates throughout the ventricular system, through the foramen of 
Magendie and the foramina of Luschka, into the SAS.   Circulation is essential for 
nutrient exchange and protection of the structures of the CNS.   If drainage is inhibited or 
CSF cannot be absorbed, brain homeostasis is disturbed.   Compensatory mechanisms 
such as intraparenchymal fluid absorption can cause cellular damage and a cortical 




1.1.4 Known pathophysiology of hydrocephalus 
 While the pathophysiology of hydrocephalus is multifactorial and involves a wide 
variety of brain injury mechanisms [2, 17, 19-20], neuroinflammation plays a major role 
and results in the activation of inflammatory cells throughout the cerebrum.   Dilation of 





become compressed and distorted.   This process undoubtedly creates primary injury 
resulting in secondary pathophysiologic mechanisms such as inflammation.   Stretch, 
BBB breakdown, cerebral ischemia, and edema lead to hypertrophy and proliferation of 
microglia and astrocytes within hours of initial insult [2], which accelerates pro-
inflammatory cytokine responses and releases neurotoxic mediators [21].  Microglia 
migrate to sites of brain lesions and sites of physiological stress, but also target astrocytes 
by producing biochemical mediators/cytokines, such as tumor necrosis factor alpha 
(TNF-α), interleukin-1(IL-1), and interleukin-6 (IL-6) [22], and secrete other pro-
inflammatory cytokines (e.g.,  monocyte chemotactic protein-1 (MCP-1) and interleukin-
1 beta (IL-1β) [23]).   Generally, inflammatory reactions occur in the periventricular 
white matter (especially in the white matter adjacent to the dorsolateral angle of the 
frontal horns), in subcortical structures and throughout the cortical mantle [2, 17, 24].   
That is, hydrocephalus generates activated inflammatory cells.   These reactions are 
prominent in the hydrocephalic brain. 
 
1.2 Hydrocephalus Treatment 
 In the United States, two of the most common methods to treat hydrocephalus are 
surgical management by endoscopic third ventriculostomy (ETV), and shunting [25].   
An endoscopic third ventriculostomy is a surgical procedure done to create an alternative 
pathway for CSF outflow from the third ventricle to the SAS.   ETVs are successful 
mainly in treating obstructive hydrocephalus [26] and are usually only appropriate for 





infants or early neonates because these patients usually have an underdeveloped SAS.   
Following surgery, gliotic scarring of this artificial channel can block flow.   It is 
estimated that up to 75% of ETVs fail within six months of surgery [27].   ETV failure is 
higher in children less than six months of age than in older patients [28] and is especially 
common in patients in their first two to four months of life [29].  Unfortunately, these 
factors cause a high percentage of patients to seek treatment through shunting. 
 Shunting is the most common treatment for hydrocephalus and can include the 
implantation of an externalized drain (external ventricular drain), an internalized drain, or 
insertion of a ventricular catheter and closed shunt reservoir (often termed Ommaya 
Reservoir).   An external ventricular drain (EVD) is placed to temporarily relieve high 
intracranial pressure.   This is an in-patient procedure that is often done in the case that 
infected or blood saturated CSF must be diverted before a permanent internalized shunt 
system can be inserted or in the case where high ICP can be alleviated in a short time.   
An Ommaya Reservoir is inserted in premature infants or infants less than 2000 grams 
who tend to have an underdeveloped immune system that may not tolerate insertion of an 
internalized shunt system.   It consists of a ventricular catheter and a closed bulbous 
reservoir that allows the neurosurgeon access to the ventricular space.   In order to 
remove any accumulating CSF from the ventricular system, the Ommaya Reservoir must 
be intermittently tapped.   In most cases of hydrocephalus, however, a patient becomes 
dependent on a permanent internalized drain (herein referred to as a shunt system) 
comprised of a proximal and distal polydimethylsiloxane (PDMS, silicone) catheter 





Proximal catheters are placed in the ventricular or lumbar system where the distal 
catheter is inserted into a drainage site (usually the abdominal peritoneum, cardiac 
atrium, or subcutaneous/subgaleal space as noted in Figure 2).   Shunt systems are the 
primary treatment for hydrocephalus, but residual deficits (listed above) occur often in up 
to 78% of patients [4].   Most importantly, the failure rate for shunts is one of the highest 
of all neurosurgical procedures equating to a disproportionately high revision to total cost 
ratio [30-32].   Shunt revisions due to shunt failure account for 70% of hydrocephalus-
related surgeries [33].   The costs to our society can be measured by lives lost following 
shunt failure, morbidity, lower quality of life for patients and their families, and the 
annual $1.4-2 billion direct cost of hospital care for pediatric hydrocephalus alone [33-
34]. 
 
1.3 Current Technologies and Their Limitations 
 Why do these shunt systems fail?  (1) The complex and variable etiologies of the 
disorder:  The pathology of hydrocephalus is multifactorial and includes primary 
(ischemia/hypoxia, compression, BBB breakdown) and secondary (gliosis, cell death, and 
CSF stagnancy) injury mechanisms that can contribute to shunt failure in a patient-
dependent manner.   Other patient-dependent variables such as rate of cortical re-
expansion can shift catheter orientation and cause obstruction.   We are only beginning to 
understand these complex relationships by studying the pathophysiology of 
hydrocephalus.  (2) Shunt infection:  After initial shunt placement, CSF infection rates 





infection is related to patient health and immune response, surgical technique and site 
preparation (operating room and patient), and long term care.   Latent infections can 
occur and are treated by shunt externalization, shunt removal/external drainage insertion, 
and antibiotic treatment [36].  In the United States, infection rates are on the decline but 
they are still unacceptably high.   Clinical trials using antibiotic loaded catheters 
(Bactiseal®) may or may not advance this field [37-38].  (3) Shunt design:  The modern 
shunt catheter is made from silicone, a hydrophobic elastomer.   At the ventricular end, 
the catheter walls have access holes for CSF outflow from the ventricular space into the 
catheter.   Downstream, a pressure valve regulates flow but flow parameters through the 
shunt system can also change as a result of patient positioning and can result in flow 
stagnancy for as long as 10 min (Joseph Madsen, personal communication).   From the 
valve to the absorption site, a distal catheter transfers CSF.  Because of the synthetic 
nature of the silicone polymer and the overall design of the system, shunts malfunction.   
The shunt system was designed in 1955 [39].  Since then, the valve characteristics have 
been manipulated (including the addition of differential pressure valves, programmable 
valves, valves that protect against siphoning, and valves that regulate outflow based on 
CSF production), but adaptations to the catheter's overall design or material properties 
have been limited [40].  But, shunts still fail, primarily because the focus has not been on 
preventing the most common type of shunt malfunction directly.    
 The most common type of shunt malfunction is tissue obstruction [41-43].    In 
the United States, complications due to tissue obstruction occur in up to 61% of patients 





after ten years [45-46].   Obstruction is the major cause of shunt complications in under 
developed areas as well.   In sub-Saharan Africa, 54% of shunts are removed because of 
obstruction [47].   Obstruction of catheters is multifaceted [42] and can include 
obstruction via whole tissue choroid plexus, inflammatory cells, connective tissue, red 
blood cells, platelets, and cell debris.    
A tabulated outline of significant findings from studies of malfunctioned shunts 
(Table 1) exposes profound evidence of inflammatory reactions in or around many 
obstructed shunt systems.   A thorough study on the histopathology of tissue obstructing 
catheters revealed that 14% of catheter obstructions included acute inflammatory cells, 
49% possessed chronic inflammatory cells, 40% contained glial tissue, and 48% having 
granulomatous cells [48-49].   A study by Gower and his colleagues suggested that the 
development of CSF eosinophilia (enhancement of the concentration of white blood 
cells) was correlated to shunt failure [50].   This response is persistent until host cells 
completely encapsulate the shunt system and is indicative of a foreign body response 
(FBR) initiated by inflammatory cell adhesion (see section 1.4).   The significance of this 
problem increases because patients with multiple revisions appear to have a greater 
chance of developing an immune reaction to the shunt system [51].     Since most patients 
with hydrocephalus receive a shunt, and because most shunts fail repetitively, we would 
expect the number of patients with an inflammatory derived occlusion to dramatically 
increase over time. 
Although analysis of explanted shunts has revealed the types of cells bound to the 





Cells from CSF, from the parenchyma, and from the blood can infiltrate the local space 
around the catheter and adhere to and encapsulate the catheter, infiltrate the holes, or 
infiltrate the holes and occlude the catheter lumen.   The CSF of a hydrocephalic patient 
can be filled with multinucleated cells of the monocyte/macrophage family, glia, 
ependymal cells, and lymphocytes [52-53].   Because the catheter is bathed in CSF, these 
cells can bind to the catheter through individual cell-catheter contact.   These cells may 
have a parenchymal or blood-borne origin.   Neoplastic cells from the parenchyma may 
migrate to the CSF to contact the shunt system purposefully (via an inflammatory 
response to the catheter) or accidentally (through shedding of the ependymal cell lining 
or periventricular white matter as an effect of high ICP).   Blood-borne cells may cross 
the blood brain barrier (BBB) due to BBB breakdown.   As a result of these mechanisms, 
cells are found scaling the wall of the catheter, attached and activated, invaginating 
catheter drain holes, and encapsulating the catheter in its entirety.    
 
1.4 The Foreign Body Response to Central Nervous System Implants 
1.4.1 Initiation of the foreign body response: exudate/tissue 
 The foreign body response (FBR) is a series of events that produce a local 
inflammatory and wound healing response around an implanted medical device, 
prosthesis, or biomaterial.  This reaction sequence can occur in tandem to activation of 
inflammatory cells by hydrocephalus.  The FBR to a shunt system is similar to the FBR 
seen around most other medical devices [54], but it differs compared to non-CNS 





mechanisms of the BBB (despite some BBB malfunctioning through implant insertion 
[55] and hydrocephalic insult [56]).   Currently, it is assumed that the FBR to the shunt 
system is identical to other CNS implants and is described in this background as such, but 
direct exposure of the ventricular catheter to high pressure and pulsatile CSF flow rather 
than direct brain tissue contact may drastically alter the reaction/rate of reaction. 
 Initiation of the FBR occurs during surgery.   Despite attempts to minimize 
invasive procedures, most surgeries cause injury and trauma at the surgery site.   Trauma 
due to shunt insertion causes infiltration of blood into extracellular space, damage to 
extracellular matrix components, and an influx of chemokines and phagocytes.   These 
reactions can accelerate blood brain barrier dysfunction around the catheter [57], 
effectively increasing CSF protein concentration.  Following this, a localized nonspecific 
acute response develops where inflammatory products from the parenchyma infiltrate the 
CSF [58].   To accelerate the inflammatory response, circulatory proteins like 
complement proteins promote mast cell degradation to increase vascular permeability and 
increase local chemotactic substances.   The activation of T-lymphocytes from outside 
the leaky BBB occurs through dendritic cells in the choroid plexus and meninges.   
Active T-lymphocytes then cross the BBB in order to recognize antibody-antigen 
complexes as nonself.   Phagocytes such as microglia, supraependymal macrophages, 
astrocytes, and blood-derived neutrophils and monocytes (later activated macrophages) 
increase proinflammatory cytokines and release reactive oxygen free radicals among 
others in a cyclic process which continues into a chronic inflammatory response [59].   





to the formation of an astrocytic capsule around the implant like those found surrounding 
the ventricular shunt catheter.  Chronic contact with the meninges may further accelerate 
this inflammatory response [55].    
 In the treatment of hydrocephalus, the initiation of the FBR causes trauma to 
cortical tissue and to vasculature already impaired with the neuroinflammatory responses 
of the hydrocephalic brain.   Thus, both the insertion of the ventricular catheter and the 
secondary responses to hydrocephalus produce cells that are known to obstruct catheters.   
Combined with concurrent inflammatory signals that are part of the injury mechanisms 
associated with hydrocephalus, the FBR induces a chronic inflammatory response. 
 
 
1.4.2 Initiation of the foreign body response: biomaterial 
 Simultaneous to inflammatory reactions occurring in tissues and in the CSF 
surrounding the catheter is the reaction that occurs directly at the CSF-shunt catheter 
interface.   Here, opsonization occurs, the process by which the material is covered by 
any available molecule that might enhance phagocytosis.   Opsonins like CSF and tissue 
fluid proteins, complement, and antigens adsorb to the catheter within seconds of 
implantation in response to the nature of the surface, specifically via electrostatic 
interactions, hydrogen bonding, dispersive forces, and the hydrophobic effect.    
Opsoninization results in surface bound ligands that can provide sites for specific 
inflammatory cell and antibody attachment in order to initiate the innate and adaptive 
immune response [61].   Monocytes, microglia, and macrophages bind to the surface in 





inflammatory mediators are enhanced [62].   Through alternative activation involving the 
surrounding active T lymphocytes and macrophage mannose receptor upregulation, 
macrophages and microglia fuse to become foreign body giant cells.   This process lasts 
the duration of the implant, and in the last stages of implant efficacy, astrocytic end feet 
and collagen form a sheath around the catheter [54].   The end-stage encapsulation of the 
shunt system is a reaction similar to the fibrotic scarring around any other medical device 
[63-65] but varies in rate of action because of the location of the implant.   Specific 
surface modifications have been employed to inhibit the initiation of the foreign body 
response, as discussed in more detail below. 
 
1.5 What Is the Best Model for Inflammatory Cell Adhesion on Shunts? 
 Modeling the inflammatory response to shunting without using the human body is 
quite a challenge.   There are several excellent in vivo congenital and experimental 
models of hydrocephalus that can be shunted with down-sized or clinical hardware.   Rats 
can be shunted with down-sized hardware; clinical hardware cannot be used because of 
size constraints of the rat skull.   However, alteration to the dimensions of the hardware 
can alter binding mechanics as is evident with failure of down scaled vascular grafts [66].   
The skull size of felines permits the insertion of clinical hardware and is an excellent in 
vivo model of hydrocephalus [67] but the cost of these large animals restricts their use.   
Collectively, in vivo models have demonstrated that cell death, reactive astrocytosis and 
microgliosis, errors in neuronal connectivity and transmission, and neurotoxicity via BBB 





18, 68].   Because obstruction of the shunt system is a multimodal problem, it is difficult 
to test problems univariably in any in vivo model.   In vitro modeling is quite controllable 
in this way.   Because the design of this work is driven by specific mechanistic 
hypotheses, an in vitro model was chosen.  In vitro modeling is capable of narrowing our 
search parameters for an ideal modification to the shunt device in an inexpensive manner.    
 There is a need for an in vitro system that could measure adhesion of cells on 
catheter tubing material in a physiological environment because shunt failure is 
undoubtedly an effect of poor understanding of shunt failure mechanisms.   There is a 
rich literature base on in vitro models designed specifically to mimic particular in vivo 
conditions.   The most applicable current model is the parallel-plate flow chamber aimed 
to simulate in vivo shear stress effects on bound cells including endothelial and bone.   
Previous work done with this model has demonstrated that mechanical stresses influence 
the orientation of bound cells [69].   The parallel-plate flow chamber could be used to 
measure cell spreading under fluidic conditions seen in hydrocephalus and could be 
adapted to measure initial cell adhesion by propelling cells through the system as has 
previously been done with platelets [70].   However, the  rectangular dimensions of the 
flow chamber do not mimic the boundary conditions of a catheter used to treat 
hydrocephalus which may change flow vector fields [71].   The focus of Chapter 2 is to 
adapt the parallel-plate flow model to measure initial macrophage and astrocyte adhesion 
on catheter material while mimicking intra-ventricular conditions and maintaining similar 





us gain an understanding of how the catheter environment influences adhesion (Chapter 
3).   
 
1.6 Modifications to Reduce Inflammatory Cell Binding 
 When designing a device, an engineer must consider the desired life and location 
of the implant, processing restrictions, and the implant composition (mechanical 
properties, bulk chemistry, molecular weight, morphology, geometry, and surface 
properties such as surface functional groups, charge, roughness, and energy).   To design 
a shunt system used in the treatment of hydrocephalus, these design factors must be 
considered, but there is little historical evidence to suggest that all of these parameters 
were explored when the shunt system was first designed.   As a consequence, the shunt 
system has undergone adaptations.    
 Since the invention of the shunt system, there have been many adaptations to the 
shunt valve (not discussed), but there have been only a few attempts to combat rates of 
obstruction; these include removal of the obstruction during surgery (Table 2) and 
modifying the catheter material or architecture in the laboratory (Table 3).   
Unfortunately, most of these strategies have failed due to inconsistencies in the 
technique, injury to the surrounding tissues, or insufficient data collection.  For instance, 
use of electrocautery to clear a catheter that afterward remains implanted is not standard 
practice because of the potential risk for thermal injury [72].   Here, essential 






1.6.1 Modifications to surface properties to reduce inflammatory cell binding 
In 1955, silicone was chosen as the primary shunt material since it is unusually 
stable at extreme temperatures [39, 73].   In elastomer form, silicone is 95% cross-linked 
and has a high tensile strength, and high resistance to tear and fatigue flexing.   These 
mechanical properties are optimal for chronic implantation of shunt systems because of 
the material's allowance to contort its shape depending on the state of the ventricular 
space without causing additional harm to the fragile nature of the ventricular lining.   
Silicone is manufactured by condensation copolymerization of dimethyldichlorosilane 
with water [73] which can permit further polymerization with additives that can enhance 
radiopacity like barium sulfate [74].   The geometry of present day catheters is created 
using a cast molding process where tubes are formed with a closed ventricular tip.   Holes 
are subsequently made in the catheter wall using a mechanical punch.   Silicone can be 
sterilized by ethylene oxide, dry heat, or irradiation, has an indefinite shelf life at ambient 
temperature, and after its initial use in 1955 was considered generally inert, non-
degradable, and biocompatible [75-76].    
 Because silicone fit so many design requirements, it is easy to understand why 
silicone was first used and why it is still used.   Today, silicone polymers have a wide 
range of applicability including implants made for ophthalmology, plastic/reconstructive 
surgery, orthopedic surgery, cardiology (blood-contact), and microfluidic devices [77].   
However, there is a high demand to tailor the surface chemistry of silicone.   Silicone, a 
hydrophobic polymer (detailed below), can elicit an inappropriate response at some 





Chapters 4 and 5 will focus on the modification of the surface wettability and  surface 
available functional groups of silicone using the developed and tested in vitro model of 
Chapters 2 and 3. 
 The term surface wettability describes the phenomenon where water is attracted to 
certain surfaces but is repelled by others.   This is likely due to a balance between surface 
adhesive and cohesive forces.   Hydrophobic surfaces can be described as those with less 
Lewis acid or base functional groups that can interact with water, so they are non-
wettable and water fearing.   Hydrophilic surfaces, or more wettable and water loving 
surfaces, can interact with water through water-water hydrogen bonding driven by 
surface energy.   These interactions, in combination with other inter- and intramolecular 
forces, drive protein adsorption [80-82].  On a hydrophobic surface like silicone, a 
biological response can be initiated through an entropic drive for the hydrophobic 
moieties of proteins in solution to bind onto the implant.   In most conditions, this 
response will be stronger on hydrophobic materials inducing more cellular activation and 
spreading than on hydrophilic materials [83].   For instance, hydrophobic 
polytetrafluoroethylene used in blood-contact devices has been shown to activate 
monocytes [84].    However, there is certainly a broad range of literature suggesting that 
cell attachment is minimal at both hydrophobic and hydrophilic extremes [85].   For 
example, tissue culture polystyrene, with a more hydrophilic surface composition than 
nonmodified polystyrene, is well known to support adhesion more than its nonmodified 
counterpart [86].  Modifying the degree of wetting (wettability) is an extremely useful 





relationship between surface wettability and adhesion is dictated not only by alterations 
in surface properties but also by environmental conditions, charge [58, 88], and 
roughness [89] in which the material is surrounded [79, 90].    
 In 1991, a new ventriculo-subdural shunt system was used in a small clinical trial 
made entirely of poly-2-hydroxyethyl methacrylate (pHEMA), a hydrophilic polymer that 
often has a gel-like consistency in water [91].   Out of the eight patients who had the new 
catheter inserted, three patients' intracranial pressure returned to normal without a change 
in ventricular size and four patients improved but still had signs of progressive 
hydrocephalus.   This study focused on the revival of the abandoned ventriculo-subdural 
shunt approach and the use of pHEMA was only briefly discussed.   In one case, the 
material caused only a mild tissue reaction and was patent upon removal seven months 
after insertion.   However, histological analysis of the other six removed catheters 
suggested that a fibrous membrane originating in the subdural space spread and 
encapsulated the entire device.   The reason for this encapsulation was not speculated 
upon but could be due to either the material (pHEMA) or the atypical use of a ventriculo-
subdural shunt.  The use of pHEMA and the ongoing success of some hydrogels in 
inhibiting protein deposition on contact lenses and other materials [92-93] might suggest 
that pHEMA may have reduced or delayed scarring compared to controls, but we cannot 
come to this same conclusion here because of the multiple variables in the study.   Since 
cells often bind more efficiently to hydrophobic surfaces [85] and less effectively to soft 
modulus materials like hydrogels [94-95], pHEMA (with its hydrophilic and gel-like 





modification to current catheter design in future studies.   This study underscores the 
necessity to study how alterations in the material or surface type impact device 
encapsulation independently.    
Another modification to the silicone shunt system was the coating of polyvinyl 
pyrrolidone (PVP) onto the surface of silicone.   PVP is a hydrophilic water-soluble 
polymer.   Applied onto a shunt catheter, PVP was marketed as Bioglide® by 
Medtronic® and sold as a catheter that would increase lubricity in order to ease insertion 
[96].   Bioglide was used by many neurosurgeons until it was taken off the market in 
2010 because the catheter was so lubricious that it failed to stay attached to the polymeric 
joints linking the ventricular catheter to the valve.   Although Bioglide® is now viewed 
by many as a failed modification, there is no study to date that describes the longevity of 
these coatings grafted onto silicone and there is no correlation between the coatings and 
inflammatory cell adhesion.      
 Although this study will not compare proposed surface coatings to Bioglide 
catheters, the scientific rationale behind their ability to reduce macrophage or astrocyte 
attachment (i.e., hydrophilic surface modification) is similar.   Protein adsorption and cell 
adhesion on photochemically immobilized PVP and polyethylene glycol (PEG) on 
silicone have been compared in other work which suggested that the PEG surfaces elicit 
very low pro-inflammatory cytokine secretions from monocytes; the degree of monocyte 
adhesion between PVP and PEG on silicone was not significantly different [97].   We 
have chosen two coating types (discussed below, including PEG) that may begin to help 





will expand on this need and will explore other material types like Bioglide® that can be 
correlated to shunt failure rate.    
 
 
1.6.2 Modifications to drainage architecture to reduce  
inflammatory cell binding 
 
One of the primary failure sites of current shunt devices is in and surrounding the 
holes of the ventricular catheter.   The ventricular end of the shunt system typically 
includes 32 500 μm diameter holes oriented in four rows that permit CSF outflow from 
the ventricular space.   Perhaps manipulation of the catheter design can inhibit 
obstruction.   Like surface properties, there is knowledge to be gained from the literature 
on other medical devices such as studies on porous materials, flow, and shear.    
Porous materials, with holes of varying morphology, are commonly found in 
dialysis equipment, hernia repair, and tissue engineering applications.   A comparison of 
adhesion and infiltration on and through porous materials and ventricular catheters is 
limited, primarily because of their dissimilar implant environment and the estimated 100 
fold difference in hole size.   However, we may be able to gain inspiration from previous 
work on porous materials and apply this knowledge to the architecture of the ventricular 
catheter.   For instance, studies that suggest that the biological response to porous 
materials is greater when the morphology of the pores is mesh-like compared to when it 
is composed of cylindrical holes [98-99].   Conceivably a similar correlation should be 
studied by examining differences between cylindrical holes and mesh-like drainage 





Perhaps the degree of inflammatory-derived obstruction is dependent on another 
component to shunt design: the configuration of the drainage holes.   In the porous 
membrane literature, components of the foreign body reaction are dictated by the 
pore(hole) size of porous materials [100-101].   On devices under flow, the literature 
implies that adhesion is dependent on shear stress [102-103].   Shear stress through the 
holes of ventricular catheters can be manipulated through alterations to the flow 
impedance through each hole.  This can occur by adapting bulk flow (pharmacologically 
or through manipulation of the diameter of the catheter), by altering the number of 
drainage holes, or by altering the diameter of the holes.   There are no publicly available 
records indicating why the number of holes, the size of each hole and the distance 
between holes was chosen when shunts were originally designed.   The focus of Chapter 
6 is to determine if inflammatory cell adhesion is dependent on the diameter of 
ventricular catheter drainage holes. 
There is clearly an urgent need to inhibit occlusion of catheters used in 
hydrocephalus.   Data suggesting that a high percentage of obstructive lesions contain 
inflammatory cells together with evidence suggesting that this foreign body response is 
one of the major contributors to shunt failure inspire us to study these interactions.   
Currently we do not understand how macrophage and astrocyte binding is impacted by 
physiological parameters such as flow, pressure, or pulsation frequency, nor do we know 
how adhesion changes under these conditions as a function of surface chemistry or shear 
stress.   In an effort to understand cell-contact induced obstruction and to find ways in 





measures inflammatory cell adhesion under fluidic conditions seen in hydrocephalus.   
With a team of highly skilled and motivated neurosurgeons, physiologists, and engineers, 
we can begin to fill these gaps in our knowledge and design a catheter that inhibits 






Figure 1  Schematic of CSF flow.   Through communication of the lateral, third, and 
fourth ventricles, cerebrospinal fluid can escape to the subarachnoid space where it can 
be absorbed through the arachnoid granulations or out to lymphatic sites.   Image adapted 






Figure 2  Common types of shunt systems are described as ventriculo-peritoneal (V-P) or 
ventriculo-atrial since they divert cerebrospinal fluid from the ventricles to either the 
peritoneal cavity or the cardiac atrium where fluid can be absorbed.   Image adapted from 




Table 1 Significant findings from catheter explants  
Year  Author [ref] Implant Type Methodology Scientific Contribution 
1981 Go  
[106] 
Malfunctioning ventricular shunts Histological Dead cell debris-related obstruction month one; Choroid 
plexus related obstruction 3-6 months following insertion 
 
1982 Sekhar  
[49] 
Malfunctioning ventricular shunts Histological Top five tissue types found: connective, chronic 
inflammatory, granulomatous, glia, choroid plexus 
 
1984 Gower  
[107] 
Malfunctioning and non-
malfunctioning (elective removal) 
distal shunts 
SEM Malfunctioning and non-malfunctioning both had bound 
protein layer; Non-malfunctioning: single cells and rare 
clusters; Malfunctioning: more cells, cell clumps, 
reactive with foot processes 
 
1985 Bigner  
[53] 
Malfunctioning ventricular shunts Cytological Histiocytic giant cells and ependymal cells in 
cerebrospinal fluid; Choroid plexus in ascitic fluid 
benign 
 
1986 Del Bigio 
[108] 
Silicone tubing Histological, 
TEM, SEM 
Silicone chemical factors and mechanical factors 
(pressure, stretch) may correlate to periventricular 
reaction and reaction at silicone-tissue interface 
 
1989 Kossovsky  
[109] 
Malfunctioning shunts (patients 
with repeat failures) 
Pathological Obstructions associated with repeat failures 
Abundance of eosinophils and evidence of active 
inflammatory processes 
 
1989 Snow  
[51] 
Malfunctioning shunts 
(ventricular, valve, abdominal) 
Pathological Patients with three or more revisions (48% of study 
population): eosinophils and giant cells in tissue 
enveloping shunt 
 




Foreign body tissue reaction on all explants;  
Defects caused luminal tissue migration or adherence  












Malfunctioning shunts Histological, 
SEM 
Inner lumen filled with granulomatous connective tissue, 
reactive glial tissue, and giant cells; reaction may 
correlate to aged silicone (material breakdown) 
 
1998 Del Bigio  
[48] 
Literature Review N/A Mechanically obstructed by mostly vascularized glial 
tissue and/or choroid plexus; inflammatory cells on over 
half of samples 
 
2004 Cinalli [111],  
Clyde [112] 
 
Malfunctioning distal shunts  N/A Cracks in silicone caused by barium sulfate impregnation 
(for radiopacity) instigate an inflammatory response 
 
2004 VandeVord  
[113] 
Malfunctioning distal shunts Molecular 
Techniques  
Enhanced protein deposition resulting in increased 
immunologic response  
 
2008 Ellis  
[114] 
Malfunctioning shunts CSF analysis Unpolymerized silicone may increase failure  
via persistent eosinophilia and hypersensitivity 
 
2009 Czernicki  
[115] 
Shunts (ventricular, lumbar, 
peritoneal) 
Histological Focally attached cells (RBC, WBC, platelets, 
lymphocytes, macrophages, mast cells); cells in fibrin 











Table 1 continued 






Table 2  Surgical device modifications to remove or avoid shunt obstruction  
Year Author [ref] Model Method Time Significant Findings 
1976 Ono  
[117] 
Human Combined aspiration 
and modified  
spinal needle 
 
Postocclusion 80% of patients' catheters patent post 
procedure that were otherwise occluded 
1994 Ventureyra 
[118] 
N/A Electrocautery within the 




Postocclusion Concept proposal only; comments suggest 
that technical problems may be difficult to 
overcome 
2003 Kehler  
[26] 
Human Peel away ventricular 
sheath 
Preocclusion Within one year, 13% less shunts required 
revision presumably due to less 
parenchymal intrusion during insertion 






of Catheter Lumen 
Postocclusion 85% success rate 
2006 Ginsberg 
[120] 




Ultrasonic Cavitation Postocclusion Low frequency ultrasound removed at least 
90% of the occluded holes  
2010 Camlar  
[121] 
Cadaver Peel away ventricular 
sheath 
Preocclusion Significantly less plugged holes following 








Table 3 Modifications to catheter material or design to prevent obstruction  
Year  Author  
[ref] 















Haase [124] and 
Browd [42]  
Human Flanges (Portnoy Catheter) Choroid 
Plexus/Whole 
Tissue 
Added flanges to prevent tissue infiltration, 
Zumstein suggests little success, Haase suggested 
inhibits choroid plexus obstructions; Browd 
suggested no decrease in obstruction rate 
 
1982 Nakamura  
[125] 
 





Air cell to inhibit obstruction by maintaining a 
distance between tissue and the catheter tip; 
functioned well over first 19 months but further 
analysis suggested the device was unsuccessful 








38% functioned but subdural design prevented 
pHEMA specific conclusions 
 









Bacteria Did not prevent bacterial adhesion; e-PTFE 
occluded rapidly with tissue 
2001 Watson  
[126] 
N/A Polyether sulfone or other 
porous fiber membrane 
Whole Tissue Patent suggests small holes of porous materials 






Product, Ellis  
[114] Report 
Human Extracted silicone 
(removal of unpolymerized 
oligomers) 
Inflammatory May work well for patients with immune 
hypersensitivity to silicone but no formal report 

























such but tested) 
 
Decreases initial bacterial colonization; May 
induce abscess formation  
 
1981 Codman® Product, 
Bayston 




Bactiseal® Bacteria Effectiveness was dependent on impregnation 




Benchtop Rivulet™ (graduated inlet 
hole diameter, compressed 
inlet placement) 
 
Flow  Flow through each hole is equalized (standard 




Benchtop Cellulose Acetate 
Ventricular Catheter 
Choroid Plexus Sufficient flow can be produced from porous 








Silicone sheets modified 





Heparin and Hyaluronan increased astrocyte and 
choroid plexus cell growth compared to PDMS; 
silanes reduced astrocyte but not choroid plexus 









Bacteria Cast molding decreases burst effect; rifampicin 
decreases initial bacterial colonization 
 Table 3 continued 
Year  Author  
[ref] 
Species Implant Type Target to  



























Microactuators removed an average of 37% 
adherent cells; cell clearing capability increased 
dependent on actuation duration and angle of 
deflection. 
 




Bacteria CSF cultures were negative after use when 
initially positive however no conclusions about 
bacterial adhesion were made 
 
2010 Thomale  
[116] 
 
Human Decreased number of 
drainage holes 
Parenchyma Without decreasing total flow velocity, fewer 
holes may decrease the risk of tissue infiltration 
but further study required 
 
30 
Table 3 continued 
Year  Author  
[ref] 
Species Implant Type Target to  














DEVELOPMENT AND TESTING OF A NOVEL IN VITRO MODEL TO SIMULATE 
MACROPHAGE AND ASTROCYTE ADHESION ONTO SILICONE  
CATHETERS USED IN HYDROCEPHALUS 
 
2.1 Introduction 
 One of the main impediments facing hydrocephalus treatment is the high rate of 
shunt failure, which is commonly caused by shunt obstruction [42, 44, 138-139].   
Cytological analysis of ventricular catheter explants has revealed a definite inflammatory 
response manifested as layers of microglia/macrophages and astrocytes surrounding 
catheters, infiltrating the flow input holes, and clogging the lumen [48].    
 A major obstacle to reducing inflammatory-based shunt obstruction is that current 
in vitro systems, which hold great potential for univariable and hypothesis-driven 
modeling of cell and tissue adhesion, do not incorporate pertinent physiological 
parameters.   Instead, most models used to test inflammatory cell–derived shunt 
obstruction consist of static environments that lack the dynamics of CSF flow, pressure, 
and pulsatility [133].   In vitro models that do incorporate flow, like the parallel plate 
flow model [71], do not mimic the appropriate flow vector fields seen within a catheter 
under intracranial conditions.   These technical barriers impede our understanding of why 






new strategies to inhibit obstruction.   This needs-based study begins to close these 
technical barriers through the development and testing of an in vitro flow system tailored 
to study shunt obstruction [140] through incorporation of flow, pressure, pulsatility, and 
protein concentration that mimic intracranial conditions. 
 
2.2 Materials and Methods 
2.2.1 Development of the hydrocephalus shunt catheter bioreactor 
 The Hydrocephalus Shunt Catheter Bioreactor (HSCB) was developed to improve 
analysis of the interactions between the polydimethylsiloxane (PDMS, silicone) shunt 
catheter and inflammatory cells in vitro.   The traditional waterfall model for sequential 
progress [141], where design, implementation, and verification are based on defining user 
needs and system requirements, was generally followed.   The user needs of this system 
include the capability to (1) suspend viable adherent cells in a fluid cell carrier; (2) adjust 
flow rate; (3) adjust pressure; (4) adjust fluid pulsation rate; (5) adjust fluid protein and 
cell concentration; and (6) remove and analyze a sample region for cell attachment.   The 
system requirements include (1) output of flow, pressure, pulsation rate, and protein 
concentration in a physiological range (0.25–0.30 mL/min, 70–200 pulses/min, ≤ 25 
mmHg, and 20–40 mg/dL total protein, respectively), and (2) minimal loss in cell 
viability.     
 Adjustable flow and pulsation rates were achieved using a three-channel 
peristaltic pump (Watson-Marlow® 401U/DM3, Cornwall, England), Marprene Tubing 





line transport tubing (PDMS with inner diameter 1.5 mm), a removable PDMS sample 
region (inner diameter 1.5 mm), and low total protein albumin-rich medium (0.5% fetal 
bovine serum (FBS) with an albumin additive).  A schematic is shown in Figure 3.   
Shear stress, flow rate, and pulsation frequency were calculated using this proposed 
design (Table 4).   After initial development and confirmation that set parameters fell 
within given deviations, the cell type and cell concentration were chosen, the cell 
viability on the catheter and in solution (with respect to each system component and with 
respect to time) were analyzed, the most appropriate technique to measure cell 
attachment was determined, and the sample type (catheter lumen, catheter holes) was 
decided.    
 
 
2.2.2 Measurement of deviances from set parameters 
 To assure that flow rate, pulse rate, and pressure readings were consistent with the 
values in which they were set, tolerated deviations were defined such that the system’s 
parameters fell within a particular range: ± 0.05 mL/min (flow), ± 1 pulses/min 
(pulsatility), and ± 0.5 mmHg (average pressure).   Bulk total flow of the fluid cell 
suspension was measured over time by measuring the total fluid output (mL) after 10 
min.   Pump manufacturer pulsation rate specifications were confirmed by manually 
counting the number of times tubing was compressed over 1 min.   Pressure was 
measured using a calibrated digital manometer zeroed at atmospheric pressure.   
Readings were then confirmed manually using a water column.   A sample size of three 





2.2.3 Choice of cell type: macrophage 
 Mus musculus IC-21 macrophages derived from SV-40 transformed peritoneal 
macrophages with phagocytic properties were used primarily because of their mature 
phenotype [142] and characteristic similarity to supraependymal macrophages found 
bound to central nervous system (CNS) implants [23, 143-144].   Because macrophages 
are involved in acute and chronic inflammation (see Introduction: Chapter 1.1.4 and 1.4) 
it was determined that observing adhesion would aid us in the understanding the 
inflammatory response to the shunt catheter.    
 Mus musculus IC-21 macrophages taken from a C57BL/6 mouse were obtained 
from ATCC (ATCC product number TIB-186).   Macrophages were maintained in 
RPMI-1640 medium with 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 1% penicillin-streptomycin (Sigma, St.  Louis, MO), 1% GlutaMAX (Sigma, 
St.  Louis, MO), 1% sodium pyruvate (Invitrogen, Carlsbad, CA), and 10% fetal bovine 
serum (FBS, Sigma, St.  Louis, MO).   Cultures were split at 80% confluence. 
 Twenty-four hours before cell detachment for experimental analysis, cells were 
soaked in a low concentration of albumin-rich medium (0.5% FBS with 7.5 mg/mL 
Bovine Serum Albumin, SeraCare Life Sciences, Milford, MA).  After several washing 
steps with noncationic Dulbecco's Phosphate-Buffered Saline (DPBS, Invitrogen), 
cultures were exposed to 1X TrypLE Express (Invitrogen) to initiate resuspension.  After 
a 5-min incubation period, cells were removed.   To facilitate macrophage removal, flasks 





were added to medium that was centrifuged at 275 x g for 10 min before cells were 
suspended in fresh medium. 
 
 
2.2.4 Choice of cell type: astrocyte 
 Adhesion and eventual encapsulation of the catheter is highly dependent on the 
inflammatory astrocytic reaction (see Introduction: Chapter 1.1.4 and 1.4).   Histological 
evidence suggests that an astrocytic response is prominently found surrounding many 
chronic implants of the CNS, is known to accompany hydrocephalus [2, 17], and is a 
major mediator of inflammatory-derived device failure [54, 145-148].   Testing astrocyte 
adhesion to catheters is imperative as these cells are a main component of encapsulation 
tissue.   A primary cortical astrocyte cell line from Rattus norvegicus (Sprague Dawley 
strain) extracted at embryonic day 20 was chosen for this study because of its cell 
uniformity.    
 Astrocytes were separated from other cell types within cortical tissue using a 
shake-off procedure [149].   Immediately after the dam had been euthanized with carbon 
dioxide, rat fetuses were extracted for astrocyte cultures at day 20 of gestation.   These 
procedures were approved by the Institutional Animal Care and Use Committee (IACUC) 
of the University of Utah in accordance with the National Institutes of Health Guide for 
Care and Use of Laboratory Animals.   The meninges of the embryos were removed, and 
brain tissue was minced and suspended in PBS containing 1 mg/mL DNase with 
manganese and 1X Trypsin.  After a 10-min centrifugation at 275 × g, the sample was 





Salt Solution (HBSS).  The suspension was seeded and allowed to reach confluency.  A 
shake-off procedure separated adherent astrocytes from other cell types; flow cytometry 
confirmed the presence of high glial fibrillary acidic protein (GFAP) in the dissociated 
cells.  Rat astrocytes were cultured in RPMI-1640 with 25 mM HEPES, 1% penicillin-
streptomycin, 1% GlutaMAX, and 10% FBS.  Cultures were split at 80% confluence.  
Similarly to macrophage detachment, astrocytes used for experimental analysis were 
removed from culture flasks after a 24-hour exposure to the low protein medium using 
1X TrypLE Express.    
 
 
2.2.5 Confirmation of cell type 
 To confirm that our cultures of IC-21 mouse macrophages and primary rat 
astrocytes expressed antigens specific to their respective cell types, cells in culture plates 
were immunohistochemically stained with 1:500 polyclonal rabbit anti-ionized calcium 
binding adapter molecule 1 (Iba-1,Wako) and 1:500 polyclonal rabbit anti-GFAP (Dako 
Cytomation, Glostrup, Denmark), respectively.   Cells were treated with secondary goat 
anti-rabbit IgG biotinylated antibody (1:200, Vector Laboratories, Burlingame, 
California) for 45 min at room temperature.   Avidin-biotin complex (ABC kit, Vector 
Laboratories) was added to the culture dishes for protein detection for 30 min and washed 
with 0.1 M PBS before samples were developed with diaminobenzidine (DAB Kit, 
Vector Laboratories).   Astrocytes were also stained with Toluidine blue to stain the cell 






2.2.6 Choice of cell concentration 
 A concentration of approximately 3.00 ×106/65 mL astrocytes or macrophages 
(46,000 cells/mL) was chosen for these experiments for two reasons:  (1) astrocyte 
adhesion assays on silicone have used this cell concentration with conclusive results 
[133];  (2) preliminary data from animals with hydrocephalus show nuclear positive cells 
(some with macrophage and astrocyte positive staining) in the CSF averaging 
approximately 41,000 cells/mL.   This estimate was used to support the cell concentration 
from the previously noted study [133].    
 
 
2.2.7 Cell viability with respect to system components 
 After one cycle (time for all cells to be exposed to the components once) and 
again three days after exposure (to determine longer-term effects on viability), the total 
cell count and viability with respect to each system component were analyzed using the 
Trypan blue exclusion assay.  Each group had a minimum sample size of three. 
 The effect on cell viability attributable to the compressive forces of the pump was 
tested using two groups: (1) flow facilitated by positive air pressure in a closed system 
with no pump contact, and (2) flow enabled by positive air pressure and exposure to the 
pump.   The former group compressed tubing that did not contain the cell solution 
whereas the latter compressed tubing that housed the cell solution.    
 The effect on cell viability attributable to protein concentration was tested by 





0.5% FBS and an albumin additive, and human CSF (a collection of CSF from 18 
patients, approved IRB protocol number 00036772 at the University of Utah).    
 The effect on cell viability attributable to the suspension flask was tested by 
comparing viability with and without exposure.    
 The effect on viability due to a decrease in tubing diameter (used to gate flow) 
was tested using either PDMS or Marprene tubing at the pump site.   A known caveat of 
this approach is that, although the flow rates (and therefore shear) were fixed and equal 
using both tubing types, the pulsation rate varied from 7 to 100 pulses/min. 
 The effect on cell viability attributable to the type of transport tubing was tested 
by comparing viability after exposure to PDMS, PDMS tubing with the addition of 
surface hydroxyl groups (OH-PDMS), and polystyrene-coated PDMS tubing (PS-OH-
PDMS).   OH-PDMS was obtained by placing tubing into an oxygen plasma chamber 
under a pressure of 200 mTorr and a power of 50 W for 2 min.   The polystyrene 
(STYRON® 666D) modification was performed on a subset of OH-PDMS samples by 
injecting 15% (w/v) polystyrene in toluene into the tubing lumen, distributing the 
solution using compressed air, and drying the samples overnight at 70ºC to remove 
residual solvent.   
 
 
2.2.8 Cell viability and adhesion with respect to time 
 To determine the effects of reusing the flow system on cell viability (since 
reincubating the system with cells could potentially enhance the longevity of each 





time periods using the Trypan blue exclusion assay after initial exposure.    Following the 
time period in which the total cell count was exhausted from the fluid suspension (see 
Results, approximately 20 hours), the system was resupplied with a second identical 
concentration.  Finally, the system was resupplied 24 hours later for a total three-day 
incubation period.   Cell viability data were graphed as the number of viable and dead 
cells over time and analyzed by integrating the area below the line of best fit for each 
curve.   The number of cells at the beginning and end of each exposure period was also 
analyzed for significance using statistical methods outlined below.    
 To determine whether and to what degree cell adhesion had changed because of 
the additional incubation periods, samples were removed at the end of the three 
incubations and fixed with 4% (w/v) paraformaldehyde.   Samples were cut 
longitudinally and fluorescently stained for analysis.  
 
 
2.2.9 Cell viability of cells bound to sample material 
 Catheter tubing was inserted at the sample site and exposed to either the 
macrophage or astrocyte solution.   Samples were removed from the system, cut 
longitudinally to expose the tubing lumen, and washed with 1X binding buffer.   Samples 
and any adherent cells were then fluorescently stained with 1:20 FITC-Annexin V in 
buffer containing 0.1% bovine serum albumin and 0.1% NaN3, 1:20 0.8 µM/µL ethidium 
homodimer III in PBS, and 1:20 500 µg/ml Hoechst 33342 in PBS to stain for apoptotic, 
necrotic, and healthy cells, respectively, as detailed in the PromoKine 





After a 15-min incubation period at room temperature in the dark, samples were analyzed 
using an inverted fluorescent microscope (Carl Zeiss, Germany). 
 
 
2.2.10 Confirmation of cell binding analysis technique 
 To find an appropriate technique to measure macrophage and astrocyte 
attachment after exposure to the flow system, fluorescent staining was attempted on 
longitudinally cut PDMS sample tubing after fixation with 4% (w/v) paraformaldehyde 
using actin, vinculin, and 4',6-diamidino-2-phenylindole (DAPI) to stain macrophages 
and GFAP and DAPI to stain astrocytes.    A double staining technique of actin and 
vinculin was chosen to identify macrophage cytoskeletal structure and focal contacts on 
the catheter surface to obtain a detailed perspective of macrophage morphology and 
attachment.   Samples were exposed to a 1:300 concentration of polyclonal sheep anti-
actin (Chemicon, Temecular, CA) in 0.1 M PBS followed by a 1:100 concentration of 
polyclonal donkey anti-sheep IgG with a cyanine 3 (Cy3) conjugate in 0.1 M PBS labeled 
actin filaments.   A mouse monoclonal anti-vinculin primary antibody (Chemicon) was 
then used at a 1:300 concentration identified with a 1:100 concentration of fluorescein 
isothiocyanate (FITC)-labeled polyclonal goat anti-mouse immunoglobulin G  (IgG) with 
heavy and light (H+L) chains (Chemicon).   GFAP was chosen to label astrocytes 
because of its repetitive appearance in astrocyte literature and its ability to portray 
astrocyte morphology (GFAP has been shown to partially control the shape and 
movement of the astrocyte [150]).   A 1:300 concentration of monoclonal mouse anti-





IgG - FITC conjugated secondary antibody (Chemicon).   Unless otherwise stated, all 
samples were incubated for 1 hour in the respective antibodies at 37ºC.   All samples 
were counterstained to identify the cell nuclei using DAPI diluted from 1 mg/mL stock to 
1:1000 in 0.1 M PBS for 12 min at room temperature.   Confocal imaging was performed 
using a Zeiss 510 microscope, and spectral epifluorescent images were obtained using a 
Nikon fluorescent CRI Nuance microscope system.  Images were observed using the 
Zeiss LSM image browser.    
 Three methods to analyze samples were attempted.   First, images were analyzed 
for the total DAPI surface area with respect to the total sample surface area.   This was 
done by hand-selecting the areas with software aid (Stereo Investigator, 
MicroBrightField, Williston, VT).   A second method involved analysis of the average 
percentage of blue in digital Red-Green-Blue (dRGB) space using the DAPI intensity of 
the images.   Lastly, adhesion was analyzed by removing cells, cellular debris, and 
extracellular matrix (ECM) from the PDMS sample tubing and concentrating the cell 
mixture on a microscope slide using a Shandon Cytospin 3 Cytocentrifuge (Fisher 
Scientific, Hampton, NH).   The quantity of cellular particulate on the slide was then 
quantified using pixel luminance photometry (Neurolucida, Microbrightfield).   A sample 
size of 12 was used for each analysis technique. 
 
 
2.2.11 Applicability of model to adhesion on ventricular  
catheters and through drainage holes  
 
 To determine the relevance of our model (testing luminal adhesion) to models 





measured macrophage and astrocyte adhesion on: (1) the lumen of PDMS tubing with a 
1.5-mm inner diameter and 3.0-mm outer diameter (inner and outer diameters which fall 
in the range of many clinical shunt catheter dimensions); (2) on the interior surface (the 
lumen) of commercially available ventricular catheters; (3) on the exterior surface of 
commercially available ventricular catheters.  Adhesion on the lumen of PDMS tubing 
(with inner diameter 1.5 mm) was also compared to adhesion on the lumen of PDMS 
with an inner diameter of 500 μm (the approximate diameter of the holes in clinical 
catheters).   While the latter comparison maintained laminar flow through the tubing 




2.2.12 Statistical analysis 
 The Anderson-Darling normality test was used if groups were normally 
distributed and the Bartlett’s test was used to examine the degree of homoscedasticity 
across data sets.   Parametric data were compared using either a two-tailed Student’s t-
test or a one-way analysis of variance (ANOVA).   Nonparametric results were compared 
using the Mann-Whitney U Test and the Kruskal-Wallis H Test with a confidence 
interval of 0.95 (α = 0.05).  If the null hypothesis was rejected using a Kruskal-Wallis H 
Test, an unplanned comparison of mean ranks test was applied using least significance in 








2.3.1 Measurement of deviances from set parameters 
 Verification measurements were performed to confirm that flow rate, pulsation 
rate, and intraluminal pressure fell within tolerated deviances.   The data revealed that 
flow (± 0.018 mL/min), pulsation rate (± 1 compression/min), and intraluminal pressure 
(± 0.24 mmHg) all fell within the tolerated deviances of ± 0.05 mL/min, ± 1 pulses/min, 
and ± 0.5 mmHg, respectively. 
 
 
2.3.2 Confirmation of cell type 
 Macrophages were stained positively with Iba-1 and astrocytes were stained 
positively with GFAP (Figure 4).  Adherent to the culture flask and without exposure to 
flow, both cell types exhibit extended processes. 
 
 
2.3.3 Cell viability with respect to system components 
 The compressive forces of the pump did not cause a significant decline in cell 
viability, although macrophage and astrocyte viability decreased significantly 
immediately after exposure (P < 0.01) and 3 days after exposure (P < 0.01) to either 
system setup.    
 Protein concentration did not cause a significant decay in macrophage or astrocyte 
viability except when CSF was used rather than medium (Figure 6, P < 0.01 when 
comparing pre and post conditions).   When comparing cell viability before, immediately 





number of living macrophages caused by the addition of the suspension flask (P < 0.01) 
but by changes in the protein content (P = 0.18).   When astrocyte viability was 
examined, exposure to CSF under flow conditions caused a significant decrease in cell 
viability compared with static cultures using 10% (P < 0.05) and 0.5% (P < 0.05) serum, 
but there was no significant difference in viability when comparing 0.5% serum with the 
albumin additive and CSF when cells were held in suspension with the suspension flask 
(P = 0.95). 
 Figure 7 illustrates that contact with the suspension flask caused a significant 
decline in the number of viable macrophages but not viable astrocytes.   PDMS tubing 
and Marprene tubing (in combination with flow) both caused the number of viable 
macrophages and astrocytes to decrease significantly (P < 0.05), but the difference in 
viability between these two tubing types was not significant.    
Compared with cell viability before contact, contact with PDMS and oxidized 
PDMS (OH-PDMS) each caused a significant decrease in viable macrophages (P < 0.01); 
PDMS (P < 0.05), OH-PDMS (P < 0.01), and polystyrene-coated PDMS (PS-OH-PDMS, 
P < 0.01) each caused a significant decrease in viable astrocytes (Figure 8).   The 
difference in macrophage viability after exposure to PDMS, OH-PDMS, or PS-OH-
PDMS was insignificant.   Astrocyte viability was significantly greater when in contact 
with OH-PDMS than with PS-OH-PDMS (P < 0.05).   Three days after exposure to 
PDMS, the number of viable cells was greater than after exposure to OH-PDMS (P < 







2.3.4 Cell viability with respect to time 
 Based on the number of living cells in suspension, nearly 100% of 3.00 × 106 
macrophages and astrocytes either bound to catheter tubing or were converted into 
cellular debris after approximately 20 hours of exposure to the HSCB (Figure 3).   
However, while the number of living macrophages and astrocytes in suspension 
decreased over time during the first 20 hours, the number of dead cells in suspension 
before exposure to the system (1411.25 macrophages/mL ± 219.63; 3148.90 ± 867.03 
astrocytes/mL) was not statistically different from the number of dead cells after the 20-
hour exposure (6788.46 ± 1630.95 macrophages/mL, P = 0.06; 3910.26 ± 1488.25 
astrocytes/mL, P = 0.77).   
 The number of living macrophages and astrocytes in suspension decreased over 
time (Figure 9, Table 5); this phenomenon occurred at a quicker rate with each 
subsequent incubation such that the area under the curve for the first incubation was 
significantly greater (P < 0.05) than for the second and third incubations.   The number of 
dead macrophages in suspension increased significantly in the second (P < 0.05) and 
third (P < 0.01) macrophage incubation compared with the first incubation.   The number 
of dead astrocytes in suspension was not significantly different throughout each 
incubation, although qualitative analysis suggested that the number of dead astrocytes in 
suspension in the second and third incubations appeared to increase over the first few 
hours and then gradually decrease. 
After analysis of viability of cells in solution, the degree of cell attachment was 





significant difference in macrophage (P = 0.17) or astrocyte (P = 0.26) attachment 
compared with the degree of adhesion present after one incubation period. 
 
 
2.3.5 Cell viability of cells bound to sample material 
 As seen in Figure 11, there is little to no evidence of apoptotic cells.   A majority 
of the cells appear to be necrotic with a presence of some healthy cells.   
 
 
2.3.6 Confirmation of cell binding analysis technique 
 Fluorescent staining and subsequent confocal imaging and cell removal were 
performed to determine an appropriate analysis technique.   Each of the three techniques 
was completed and data were attained successfully (Table 6).    
 
 
2.3.7 Applicability of model to adhesion on ventricular  
catheters and through drainage holes  
 
 There was no statistically significant difference in macrophage adhesion on the 
wall of the tubing lumen, on the wall of tubing lumen with a diameter equal to the 
diameter of the holes, or around the holes of the clinical catheter analyzed from the 
perspective of the lumen or the catheter exterior (Figure 12).   Astrocyte adhesion results 
followed the same pattern: There were no statistically significant differences in groups 
except for a difference between adhesion on PDMS with the large (1.5-mm) and small 
(500-μm) inner diameters (P < 0.05).   Qualitative image analysis of the clinical catheters 
suggested that macrophages and astrocytes accumulated around the drainage holes but 






2.4.1 Development of the hydrocephalus shunt catheter bioreactor 
 In this work, our in vitro flow system, the Hydrocephalus Shunt Catheter 
Bioreactor (HSCB), was developed and tested.   The model was designed to expand 
current in vitro models to improve our understanding of macrophage and astrocyte 
adhesion on catheters by mimicking intracranial flow, pressure, and pulsation rate.  After 
initial development, the cell type and cell concentration were chosen, cell viability was 
analyzed, the most appropriate technique to measure cell attachment was determined, and 
the sample configuration (catheter lumen, catheter holes) was decided.    
 
 
2.4.2 System components   
 To model CSF flow without force from the vascular system at a physiologic rate, 
a pump must be used.   A direct lift, displacement, velocity, buoyancy, or gravity pump 
could be used to attain such flow, but a peristaltic pump was chosen in order to 
simultaneously attain pulsation.   A peristaltic pump mimics the fluid displacement 
demonstrated by many biological systems, such as the gastrointestinal tract, by displacing 
fluid using a rotor with attached rollers.   A tube surrounding these rollers becomes 
compressed between the rollers and a stationary exterior surface to push the fluid 
forward.   Data suggest that the use of a peristaltic pump that induces compressive forces 
does not (by itself) decrease cell viability.   We can speculate that the decrease in viable 





 In the proposed model, we use a low-serum medium (0.5% serum plus an albumin 
additive) to mimic the total protein and albumin concentration of CSF.   Low-serum 
medium did not cause a significant difference in the number of viable cells compared 
with CSF or high-serum (10%) medium.   Speculatively, since a significant decrease in 
living macrophages and astrocytes was seen after exposure to CSF but not after exposure 
to the media solutions, a reduction in viability could have been due to factors other than 
protein concentration, including variations in amino acid concentration, glucose 
concentration, or added HEPES in the medium.   Together, this information leads to the 
conclusion that medium with 0.5% serum plus the albumin additive may be used in 
subsequent experiments. 
 To keep cells in suspension, a standard 250-mL suspension flask (Kontes 
Cytostir, Kimble Chase, Vineland, NJ) was used.   The suspension flask is made of 
borosilicate glass and is designed with a curved bottom to minimize cell adherence.   Use 
of the suspension flask caused a significant decline in the number of viable macrophages 
but not in the number of astrocytes.   A second suspension flask with a slightly different 
design (Wheaton Celstir, Braintree, MA) was used in a subset of experiments (data not 
shown), but results were similar, suggesting that the type of suspension flask does not 
alter viability.   The use of a falcon tube was also attempted, but cells did not remain in 
suspension.   Therefore, it was concluded that a standard suspension flask was required 






 As was discussed, small-diameter tubing (0.2–0.5 mm) at the site of the pump was 
required to achieve simultaneous flow and pulsation rates in a physiological range.   
Marprene tubing was chosen because of its high durometer and known resistance to 
repetitive compressions [151].   The addition of Marprene tubing into the system did not 
significantly alter the number of viable macrophages and astrocytes compared with when 
PDMS tubing was used at the site of the pump.   To maintain a similar bulk flow rate in 
both conditions, the pulsation rate varied from 100 pulses per min with Marprene tubing 
to 7 pulses per min without the tubing.   Changes in viability could have been a result of 
this varying pulsation rate or could have occurred because of a difference in surface 
chemistry.   Variability in shear could have caused a change in the number of viable cells 
in suspension.   However, none of these factors resulted in a significant difference in 
macrophage or astrocyte viability in the proposed model.   Importantly, the diameter of 
the Marprene tubing is similar to the diameter of the cerebral aqueduct in children [6].   
Therefore, any cellular response attributable to the decreased diameter may be 
physiological when comparing the system with shunt systems implanted in the fourth 
ventricle.   Together, this information leads to the conclusion that Marprene tubing may 
be used in subsequent experiments. 
 PDMS tubing was the originally proposed transport tubing, but to understand how 
the viability and total cell count change depending on surface composition, two 
modifications replaced PDMS in a subset of experiments: (1) an anti-adhesive PDMS 
surface modification (the addition of surface hydroxyl groups) to inhibit cell attachment; 





that the quantity of bound cells on PS is greater than that on PDMS [133]).   A limitation 
to this study is that more surfaces were not tested.   Results indicated that there was no 
significant difference in cell viability after exposure to PDMS, OH-PDMS, or PS-OH-
PDMS, but 3 days after exposure to OH-PDMS macrophage viability was near zero and 
astrocyte viability after exposure to OH-PDMS or PS-OH-PDMS was near zero.   
Consequently, there is no clear advantage to using OH-PDMS or PS-OH-PDMS, but 
there are disadvantages, including potential protein activation by OH-PDMS surfaces 
[85] and changes in proinflammatory cytokine release on polystyrene surfaces [23, 65, 
142].   PDMS transport tubing may still elicit a response, but may be preferred over OH- 
or PS-modified PDMS to minimize undesired changes in cellular response that do not 
occur in vivo. 
 
 
2.4.3 Exposure period 
We can predict that the loss of viable macrophages and astrocytes over time was 
due to adhesion to the tubing walls, flow-induced shear stress, and the potential for 
phagocytosis to mediate the conversion of living cells to cellular debris that is not 
counted as dead cells.   To start with the chosen concentration of 46,000 cells/mL, an 
approximate 20-hour exposure period should be used for future studies using this model. 
Analysis of adhesion after one incubation (20 hours) and after three consecutive 
incubations (20 hours + 24 hours + 24 hours) indicated there was no significant increase 
in adhesion with increased time or cell count.   This may suggest that the maximum 





saturated with cells.   These data are similar to data from other reports that suggest that 
cell adhesion onto polymers occurs over a short time when the materials are not yet cell 
saturated [90, 152-153].   This suggests that a 20-hour exposure period is most likely 
adequate.  In vivo, however, PDMS catheters are introduced to multiple cell types at 
different time-points throughout the life of the implant, indicating that a 20-hour period in 




2.4.4 Viability of bound cells 
After a 20-hour exposure period, a majority of bound cells were necrotic, a 
minority of cells were healthy, and none of the cells were apoptotic.   If we assume that 
the presence of the necrotic cells is not an artifact of the methodology, we question how 
the cells became necrotic.   From data collected in this study we know that the number of 
dead cells in solution did not significantly increase over the first 20-hour incubation 
period.   This would imply that the cell necrosis observed on the sample was likely not a 
result of cells in solution binding after death.   Perhaps these cells became necrotic after 
they had bound to the PDMS sample.   Although PDMS is not cytotoxic in the presence 
of protein and does not leach toxins [154], the low protein concentrations or the flow 
conditions at the fluid–material interface may not be conducive to viability binding.   
Clinically, the presence of necrotic debris in tissue occluding catheters is not uncommon 







2.4.5 Measuring intensity for analysis 
 Three data acquisition and analysis methods were compared.   Determining the 
quantity of attached cells by measurement of DAPI intensity surpasses manually counting 
cell nuclei because of the potential for merged or overlapping cells, its wide acceptance 
in academic research [144, 155-156], and its capability to reduce human error and 
potential bias of manual counting despite double blinding.   Using threshold values to 
count the nuclei area is a potential analysis method was but not tested here.   Analysis by 
removing cells, cellular debris, and ECM from the PDMS sample tubing and 
concentrating the cell particulate on a slide for photometric analysis is sound in theory 
but could introduce error if all the cells are not completely removed from the sample.  
Photometric analysis is not very sensitive but can provide additional information on the 
cell debris and matrix that cannot be visualized with fluorescent staining.   As seen in 
Table 6 the three methods were all successful.   Because of these factors, measurement of 
adherent macrophages and astrocytes using DAPI intensity serves as the primary method 
of analysis.   
 
 
2.4.6 Applicability of model to adhesion on ventricular  
catheters and through drainage holes 
 
 An insignificant difference in adhesion on the lumen of PDMS tubing 
(presumably where flow is laminar) and adhesion on commercially available ventricular 
catheters (where flow eddies could occur because of the catheter geometry) suggests that 
flow turbulence may not be a noteworthy factor in adhesion under in this system.   The 





shear stress) and large (with 0.0089 N/m2 shear stress) diameter suggests that perhaps 
adhesion is dependent more on changes in shear stress than possible flow turbulence 
around the catheter.   This information leads to the conclusion that PDMS tubing with a 
diameter similar to that of clinical catheters can be used in this system to mimic adhesion 
on the inner surface of commercially available catheters but should not be interpreted as 
occlusion through the holes of the clinical catheters because of a potential dependence on 
shear stress.   One aspect of Chapter 3 will focus on the effects of shear stress by 
modifying flow rate.   Additionally, the flow system will be expanded in Chapter 6 to 
include analysis on commercially available hardware to determine how changes in the 
diameter of the holes (and presumably shear stress through the holes) impacts adhesion.    
 
2.5 Conclusions 
To minimize changes in macrophage and astrocyte viability, components of the 
flow system for future experiments may include a suspension flask, a low protein 
medium solution, a peristaltic pump, PDMS transport tubing, Marprene tubing at the site 
of the pump, a sample site, and macrophages/ astrocytes.   Running the system for more 
than 20 hours appeared to have no significant impact on the degree of macrophage or 
astrocyte attachment.   Adherent cells are primarily necrotic when bound to PDMS 
samples but we can speculate that this was caused after initial attachment and was not 
caused by inappropriate modeling.   There was no statistically significant difference in 
macrophage adhesion on the wall of the tubing lumen, on the wall of tubing lumen with a 





Although the system is not without limitations, the Hydrocephalus Shunt Catheter 
Bioreactor can be used to begin to understand inflammatory cell adhesion on catheter 
material used to treat hydrocephalus.   The field is long overdue for an incremental 
advancement that permits continued progress that may improve our knowledge of shunt 




Figure 3 Diagram of the novel Hydrocephalus Shunt Catheter Bioreactor (HSCB).  A 
peristaltic pump was used to propel a cellular suspension from the reservoir (denoted 
"Spinner Flask") through PDMS transport tubing (solid black line), through the point of 
flow restriction (referring to the variable diameter of Marprene tubing used to alter flow 
and pulsation rate), through PDMS samples (either horizontally or vertically placed), and 
back to the cellular solution reservoir.   In this way, samples were exposed to pulsatile 



















































0.5 0.0301 1.5 0.0011 0.25 70 
0.38 0.0686 1.5 0.0011 0.25 100 
0.25 0.2409 1.5 0.0011 0.25 200 
0.38 0.0823 1.5 0.0013 0.3 120 








Figure 4 Representative illustrations of adherent living macrophages stained with Iba-1 
(A), and astrocytes stained positively with GFAP and Toluidine blue (B) to confirm cell 
type.   Adherent to the culture flask and without exposure to flow, both cell types exhibit 






Figure 5  Macrophage (A) and astrocyte (B) count in suspension after exposure to flow 
conditions with and without the use of the peristaltic pump.    The compressive forces of 
the pump did not cause a significant decline in cell viability.   All statistically significant 





   
Figure 6  Macrophage (A) and astrocyte (B) count in suspension after exposure to 
varying protein concentrations.   Of particular interest among the results shown is the 
insignificant difference between 10% medium and 0.5% medium or between 0.5% 
medium and CSF while using the suspension flask.   All statistically significant 





     
 
Figure 7 The effect of flow system components on macrophage (A) and astrocyte (B) 
count in suspension.   Here, "+" denotes that a component has been added to the 
preceding condition.   Contact with the suspension flask caused a significant decline in 
viable macrophages but not viable astrocytes.   PDMS tubing and Marprene tubing (in 
combination with flow) both caused the number of viable macrophages and astrocytes to 
decrease significantly, but the difference in viability between these two tubing types was 
not significant.  All statistically significant differences were determined using a one-way 












    
Figure 8  Macrophage (A) and astrocyte (B) count in suspension after exposure to 
varying surface chemistries of transport tubing.   The data suggest that there is no 
significant difference in cell count with the use of PDMS, OH-PDMS, or PS-OH-PDMS 
transport tubing immediately after exposure.  All statistically significant differences were 





   
Figure 9 Living (A) and dead (B) macrophage and living (C) and dead (D) astrocyte 
concentration over time.   Generally, the number of living cells in solution decreased over 
time, but the number of dead cells did not proportionally increase over time.  All 
statistically significant differences were determined using a one-way ANOVA as outlined 













Table 5 Average living cell count in solution with respect to time (± SEM) 
 First Incubation  
(0-20 hours) 
Second Incubation  
(20-44 hours) 
Third Incubation  
(44-68 hours) 
Astrocyte  20,368,180 ± 6,985,370 5,763,396 ± 937,508 7,588,020 ± 1,059,452 






   
Figure 10 The degree of macrophage and astrocyte adhesion was analyzed after one or 
three consecutive incubations, and no significant difference was found between groups 







Figure 11 Bound macrophages (A) and astrocytes (B) on PDMS samples stained for 
apoptotic cells (green co-localized with blue), necrotic cells (red co-localized with blue), 
and healthy cells (blue alone) using the PromoKine Apoptotic/Necrotic/Healthy Cell 
Detection Kit.   While a majority of cells appear to be necrotic, there are some healthy 
cells and no apoptotic cells.   Images acquired using a 10X objective.   The scale bar 






Table 6 Quantitative values for each analysis technique 
 DAPI Area  
(Average Percent 
Area Occupied)  
± SEM 
DAPI Intensity  
(Average Percent Blue 
Component in dRGB 




 ± SEM 
Macrophage 1.31 ± 0.33 4.55 ± 0.54 171.70 ± 0.36 







Figure 12 Degree of macrophage and astrocyte adhesion as determined by the average 
percent blue component in dRGB space (fluorescently stained nuclei).   While there is no 
significant difference in macrophage adhesion across groups, there is a significant 
difference in astrocyte adhesion when comparing adhesion on the tubing lumen (larger 
inner diameter, approximately 1.5 mm) and adhesion on the tubing with inner diameter 
equal to the diameter of a clinical catheter hole (500 μm); significance denoted with an 







MECHANICAL CONTRIBUTIONS TO MACROPHAGE AND ASTROCYTE 
ADHESION USING A NOVEL IN VITRO MODEL  
OF CATHETER OBSTRUCTION1 
 
3.1 Introduction 
Hydrocephalus is a neurological disorder that results from an imbalance between 
formation and absorption of cerebrospinal fluid (CSF).  It is often associated with 
increased and pathological intracranial pressure (ICP), which usually causes expansion of 
the cerebral ventricles.  Treatment for this chronic disorder must be individualized 
because variations exist in CSF flow rate, pulsation frequencies, and ICP.   However, 
over the last 50 years there has been little modification of the standard treatment, which 
involves implanting a silicone catheter into the lateral ventricle to drain CSF [158].  
Although this type of treatment is usually effective in draining (shunting) excess CSF 
temporarily, surgical revisions are often necessary.  The results of one retrospective study 
indicated that 85% of shunts malfunction within 10 years of implantation [45].  Another 
study  reported that the incidence of shunt failure was about 40% after one year and 50% 
                                                 
1 Reprinted from Experimental Neurology with minor additions and revisions, 222(2), Harris, CA; Resau, 
JH; Hudson, EA; West, RA; Moon, C; McAllister JP  "Mechanical contributions to astrocyte adhesion 
using a novel in vitro model of catheter obstruction," 204-10, Copyright (2010), with permission from 






by the second year after insertion [42].  Indeed, tissue obstruction of the ventricular 
catheter is one of the most common causes of shunt failure [41-43, 49].   
The most abundant cell types and tissues found attached to shunt catheters are choroid 
plexus, ependyma, and glial cells [49], which likely bind in part due to the 
chronic/foreign body inflammatory response [50, 107, 159].    
While the cell types found to obstruct catheters are known, the causes for 
adhesion and eventual obstruction are still somewhat speculative and are probably at least 
partially dependent on changes to intraventricular conditions such as changes in flow 
rate, pressure, and pulsation frequency.  Normal CSF flow is approximately 0.3 mL/min 
[11] but decreases as a compensatory reaction to hydrocephalus to approximately 0.25 
mL/min [15].   Previous studies have suggested that changing the overall flow rate can 
change cellular function [160] and cell tethering rate [102], so we hypothesized that a 
change in flow rate would change the quantity of bound cells.   The pressure within the 
ventricles and the pressure within the catheter change frequently and in most patients as a 
consequence of the disorder, but studies have indicated that pressure may alter the 
expression of specific integrins that impact receptor-ligand cell adhesion [161].   We 
hypothesized that an increase in pressure would decrease adhesion.   Finally, the average 
frequency of pulsations within the ventricles ranges between 70-200 pulses/min 
dependent on the age and activity of the patient.   Pulsatile flow as compared to static 
culture alters focal adhesion sites [162], and compared to oscillatory flow impacts 
cytoskeletal reorganization of cells and decreases nuclear factor kappa-light-chain-





that an increase in pulsation rate would decrease adhesion.   By altering parameters of 
pressure, pulsation rate, and flow rate in an in vitro bioreactor univariabily, we can 
determine if each factor has an impact on the degree of macrophage and astrocyte 
adhesion as part of the initial inflammatory response.   
 
3.2 Materials and Methods 
3.2.1 Astrocyte extraction, isolation, and maintenance 
 Procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Utah in accordance with the National Institutes of Health Guide for 
Care and Use of Laboratory Animals.   Primary rat astrocyte cultures were attained from 
rat astrocytes collected on day 20 of gestation.   Immediately after the dam had been 
euthanized, rat fetuses were extracted, the meninges of the embryos were removed, and 
brain tissue was separated.   Tissue was minced and suspended in phosphate buffer 
solution containing 1mg/mL DNase with manganese and 1X Trypsin.  The cellular 
solution was centrifuged for 10 min at 275 × g.   Following resuspension, the tissue 
particulate was sieved through an 80-μm nylon mesh and washed before it was seeded 
and allowed to reach confluency.  A shake-off procedure separated adherent astrocytes 
from other cell types.   Cells were analyzed using flow cytometry to confirm the presence 
of high GFAP in the dissociated cells.  Astrocytes were cultured in RPMI-1640 with 25 
mM HEPES, 1% penicillin-streptomycin, 1% GlutaMAX, and 10% FBS.  Cultures were 





3.2.2 Acquisition and maintenance of macrophages 
 Mouse peritoneal IC-21 macrophages were attained from ATCC.   Cells were 
quickly thawed and washed with cold DPBS before being cultured in  RPMI-1640 with 
25 mM HEPES, 1% penicillin-streptomycin, 1% GlutaMAX, 1% sodium pyruvate, and 




3.2.3 Macrophage and astrocyte detachment 
 for passaging and experimental analysis 
 
 Twenty-four hours before cell detachment for experimental analysis, cells were 
soaked in a low concentration of albumin-rich medium (0.5% FBS with an albumin 
additive).  Both cell types were washed separately with DPBS and were subsequently 
incubated in 1X TrypLE Express at 37° C to initiate resuspension.  After a 5-min 
incubation period for astrocytes and a 10-min incubation for macrophages, cells were 
removed and added to medium, centrifuged, and resuspended in fresh medium.   The 
Trypan blue exclusion assay, viable cells were counted.   Viable cells were seeded and 
suspended at a density of 180.175 cells/mm2 in either the static culture or the bioreactor. 
 
 
3.2.4 Design of static culture systems 
 Silicone surfaces were prepared in 6-well culture plates to represent a static in 
vitro culturing environment in which cells were seeded onto silicone rather than the 
culture dish base polymer polystyrene.  Silicone was prepared using the Sylgard 184 





10:1.  Approximately 1 mL of the combined solution was injected into each well and 
allowed to cure at a temperature of 60°C for 4 hours before seeding with astrocytes. 
 
 
3.2.5 Cell attachment and viability in static culture systems 
 Using methods similar to those in a direct contact cytotoxicity assay [164], 
samples were analyzed for acute cell maturation and growth.  Macrophages and 
astrocytes (0.098 × 106 cells) were seeded onto a silicone surface to yield a density of 
180.175 cells/mm2.  Cells were incubated for 20 hours at 37°C. 
 
 
3.2.6 Design of the hydrocephalus shunt catheter bioreactor  
 In methods analogous to those used in static culture, macrophages and astrocytes 
were suspended on a silicone surface at 180.175 cells/mm2 equating to a final cell 
suspension of 4.615 × 104 cells/mL (3 × 106 cells total) in the HSCB.  Cells were 
propelled through the bioreactor at 37°C.  The cells were distributed using an autoclaved 
250-mL spinner flask (Cytostir).  A three-channel peristaltic pump (Watson-Marlow 
401U/DM3, Cornwall, England) initiated flow propagation through a series of tubing 
including Marprene double manifold tubing (Watson-Marlow), barium-impregnated 
regions of silicone catheters, and barium-free silastic tubing (Silastic Rx Medical Grade 
Tubing, Dow Corning, Midland, Michigan).  The rate of flow was set to mimic 
conditions within the ventricular cavity such that variations in pressure, flow rate, and 
pulsatility were independent parameters (pump settings were chosen based on Watson-





mmHg) were induced using in-line high-pressure valves (Baxter Heyer-Schulte Mini-
LPV High Pressure Valves, Deerfield, IL), whereas low-pressure conditions (-1.66 ± 0.02 
mmHg) resulted from inherent pressure within the system with no valve used.  Flow rate 
and pulsation rate were manipulated in combination by varying the diameter of the 
Marprene tubing: 0.25 mL/min and 100 pulses/min was simulated using 0.38-mm inner 
diameter tubing; 0.3 mL/min and 120 pulses/min also using 0.38-mm inner diameter 
tubing; 0.25 mL/min and 70 pulses/min using 0.50-mm inner diameter tubing, and 0.25 
mL/min and 200 pulses/min using 0.25-mm inner diameter tubing.  When measuring 
adhesion under varying conditions of flow, no pressure valve was used and pulsation rate 
was set to 100 pulses/min; when measuring adhesion under varying conditions of 
pressure, 0.25 mL/min flow rate and 100 pulses/min were used; when measuring 
adhesion under varying conditions of pulsatility, no pressure valve was used and flow 
rate was set to 0.25 mL/min.  A removable in-line manometer was used to record mean 
pressure within the catheter.  Sample regions of medical-grade silicone shunt tubing 
impregnated with barium were fixed in horizontal and vertical positions to mimic 
prolonged supine and up-right orientation, respectively.  Sample tubing was obtained 
from the Neurosurgery Division of Medtronic (Goleta, CA).   
 
 
3.2.7 Pressure measurements 
 An Extech HD700 Handheld Digital Manometer was used to measure pressure 
within the flow system.  The total pressure in all components of the flow system was 





fluid flow was determined when the manometer was zeroed in line with the system turned 
off.   Pressure values were confirmed manually using a water column. 
 
 
3.2.8 Staining procedure for static cultures and the bioreactor 
 Following cell exposure to silicone, macrophages and astrocytes bound to each 
substrate were fixed in 4% (w/v) paraformaldehyde in PBS for two hours at ambient 
temperature.  All samples were removed from solution, immediately rinsed, stored in 0.1 
M PBS overnight at 4°C, and then longitudinally cut to prepare for staining.  Samples 
inoculated with macrophages were batch stained using a double staining technique to 
label actin and vinculin.   Samples were subsequently incubated in 1:300 polyclonal 
sheep anti-actin (Chemicon, Temecular, CA) in 0.1 M PBS followed, 1:100 polyclonal 
cyanine 3 (Cy3)-conjugated secondary antibody in 0.1 M PBS, 1:300 monoclonal mouse 
anti-vinculin (Chemicon), and 1:100 polyclonal FITC-labeled goat anti-mouse IgG H+L 
(Chemicon).   Samples inoculated with astrocytes were batch stained with a 1:300 
concentration of monoclonal mouse anti-GFAP (Chemicon, Temecula, CA) in 0.1 M 
PBS to label astrocytes.   A 1:100 polyclonal goat anti-mouse IgG (H+L) fluorescein 
conjugated secondary antibody (Chemicon, Temecula, CA) was applied for one hour at 
37°C to localize the GFAP primary antibody.  Both macrophage- and astrocyte-
inoculated PDMS samples were counterstained with a 1:1000 concentration of 1 mg/mL 





3.2.9 Imaging and quantification for static cultures and the bioreactor 
 Confocal images were taken using a Zeiss 510 microscope, and spectral 
epifluorescent images were obtained using a Nikon fluorescent CRI Nuance microscope 
system.  The confocal images were observed using the Zeiss LSM image browser.  For 
semiquantitative image analysis, 2 random spots on each tube half and on each static 
culture sample were investigated using DAPI-positive nuclei tracing (n = 12, where each 
sample included both portions of the catheter tubing for HSCB analysis).  Data were 
analyzed and represented as the percent of total blue component in dRGB space 
(analyzed using software to analyze fluorescent intensity).   Data for each condition were 
pooled and represented as the percent change from 255, with 255 representing complete 
light emission at each measured pixel. 
 
 
3.2.10 Statistical analyses 
 After analysis of data normalcy using the Anderson-Darling normality test, results 
were compared using either a one-way ANOVA or the Kruskal-Wallis H Test with a 
confidence interval of 0.95 (α = 0.05).  In cases in which two dependent hypotheses were 
tested simultaneously, the Bonferroni correction set significance at 0.025.  In instances 
where the null hypothesis was rejected, suggesting that the groups did not come from the 
same distribution, either a post-hoc Scheffe test or an unplanned comparison of mean 
ranks test was implemented using least significance in difference rank.  Power analysis 
was used to determine the beta error level and statistical power between group 






3.3.1 Flow-dependent adhesion 
 Calibration using 0.1 M PBS at corresponding pump settings and Marprene tubing 
diameters confirmed flow rates of 0 mL/min (static culture), 0.25 mL/min, and 0.30 
mL/min.  As seen in Figure 13, Figure 14, and Figure 15, fluid flux altered the quantity of 
binding macrophages and astrocytes within a 20-hour time period.  Separate one-way 
ANOVA tests for each cell type followed by a post-hoc Scheffe test indicated that there 
was a significant difference in astrocyte adhesion when exposed to static or fluidic 
cultures (P < 0.05).   There was no statistically significant difference in macrophage 
adhesion although a trend suggested that adhesion increased with flow.    Therefore, our 
hypothesis that adhesion would be altered by flow is correct in the case of astrocyte 
adhesion, but not for macrophage adhesion. 
 
 
3.3.2 Pressure-dependent adhesion 
 Using the digital manometer, total mean recorded intraluminal pressure was 
confirmed to be -1.66 ± 0.02 and 16.43 ± 0.24 mmHg with and without in-line high-
pressure valves, respectively.  Confocal images in Figure 16 and Figure 17 show no 
obvious variation between adhesion under conditions of low or high pressure.   There was 
no significant difference between groups.  Therefore, our hypothesis that adhesion would 
increase dependent on an increase in pressure was not correct.   As is apparent in the 
graphical representation of the data in Figure 18), an increase in pressure did not 





vertically fixed samples.  However, there was a trend (P > 0.05) that suggested that an 
increase in macrophage and astrocyte adhesion might be caused by a decrease or an 
increase in pressure, respectively on horizontally fixed samples.     
 
 
3.3.3 Pulsatility-dependent adhesion 
 The effect of pulsation rate on astrocyte adhesion is shown in Figure 19, Figure 
20, and Figure 21.   Although inconsistent, clumping of adherent macrophages and 
astrocytes was observed.  A significant difference was observed between macrophage 
adhesion on horizontally fixed samples under 70 pulses/min and vertically fixed samples 
under 100 pulses/min.   A Kruskal-Wallis H Test was performed on astrocyte adhesion 
without rejection of the null hypothesis (P = 0.98), which implies that the samples came 
from the same distribution when pulsation rate was varied.  Analysis with photometry 
revealed no significant variation in samples, and the null hypothesis assuming samples 
came from the same distribution could not be disputed.    
 
3.4 Discussion 
 The Hydrocephalus Shunt Catheter Bioreactor (HSCB) was used in this study to 
measure how flow rate, pulsation frequencies, and pressure changes affect adhesion of 
individual inflammatory cells.   Macrophage and astrocyte adhesion on silicone catheters 
within the HSCB were monitored by measuring the deposition of cells semiquantitatively 
using confocal microscopy.  Altered flow rate and pressure levels did not significantly 





significantly affect astrocyte deposition.  Of most interest, however, may be the 
insignificant increase in macrophage adhesion and the statistically significant increase in 
astrocyte adhesion after exposure to flow conditions compared with those observed after 
exposure to static culture.   
 The finding that cell adhesion increases as a function of increased fluid flow is 
initially quite counterintuitive.  Using known determinants that describe velocity and 
normal shear stress through tubing, as well as continuity equations, flow parameters can 
be determined that predict flow through catheters for hydrocephalus.  However, because 
cell movement becomes restricted within an occluded catheter, using these calculations to 
predict the actions of the cells together with fluid behavior becomes quite problematic.  
To understand the results that yield increased adhesion with increased flow, consideration 
of Brownian motion, a phenomenon describing the random movement of particles, is 
helpful.  In this case, transmission of thermal excitations caused by cellular collisions in 
the medium could cause the cells to undergo random walking, or movement in successive 
random directions, thus changing the distance between cell receptors and their protein 
ligands that are bound to the catheter surface [102].  A faster transport of cell-containing 
CSF would decrease contact time between cells and the catheter surface but would 
increase contact incidence [102].  These mechanisms could explain why our results 
showed enhanced macrophage and astrocyte adhesion under conditions of flow as 
compared with static culture conditions.   In our opinion, the statistically insignificant 
change in adhesion seen between 0.25 and 0.3 mL/min conditions is not sufficient to 





between static and flow conditions.   Our data would predict that adhesion under 
conditions of normal flow at 0.3 mL/min [11] would not be significantly different under 
conditions of chronic hydrocephalus where flow rate is decreased to 0.25 mL/min [15]; 
but, we have no data to indicate whether these relationships would change over longer 
periods of time.   
Another plausible explanation for observing an increase in adhesion under 
conditions of flow is that the mechanical stress may alter the chemical factors expressed 
by the cells.   Previous findings have shown that mechanical signals can be translated into 
chemical messages by astrocytes, possibly because of their interconnections within brain 
parenchyma [165].  Other studies have suggested that clustered α5β1 integrins may 
support forces during the binding of cells to fibronectin [166].  If α5β1 recruitment is 
enhanced in astrocytes under conditions of flow, cell adhesion may increase, although to 
our knowledge this has not been demonstrated.   In this study, the cells have been 
removed from their native state and propelled as individual cells, which may detract from 
overexpression of chemical messages.   However, the concept of enhanced recruitment is 
still a conceivable explanation for increased cell adhesion under conditions of flow.   
In hydrocephalus, the CSF formation rate is strongly associated with ventricular 
pressure [167-168].  Changes in either CSF flow or ventricular pressure could impact the 
microenvironment surrounding the ventricular catheter and play a major role in how cells 
might obstruct CSF shunts; however, while high pressure slightly enhanced astrocyte 
adhesion on the horizontal catheters, it inhibited macrophage adhesion on horizontal 





protein ligands and cells but are not enough to make a significant impact on overall 
adhesion after a 20-hour exposure and may actually have an inhibitory effect depending 
on the specific receptor-ligand interaction.  This pattern of adhesion may be comparable 
to adipose accumulation in hypertensive models of atherosclerosis in which chronic high 
blood pressure leads to pathologic changes in smaller arteries and arterioles; 
morphologically, this is observed in vessel wall thickness as lipids accumulate in intimal 
endothelial cells [169].   
Fluctuations in pulsation rate did not significantly impact astrocyte adhesion, and 
impacted macrophage adhesion only when it was altered concurrently with catheter 
orientation.  Frequencies of 70, 100, and 200 pulses/min were tested to model clinically 
applicable average CSF pulsation rates seen in adult, pediatric, and neonatal patients.  
Because such a narrow frequency range was chosen, it is possible that other frequencies 
outside of this range may yield changes in adhesion, but a full evaluation of pulsation 
frequency was beyond the scope of this study. 
 Our results further indicate that there is a trend toward existing surgical grade 
catheters being more vulnerable to cellular adhesion when they are parallel to the ground, 
presumably because of the effect of gravity, as astrocyte adhesion on horizontally fixed 
catheters was generally greater than adhesion on vertically fixed catheters.  These data 
might indicate a need to favor vertical insertion.   However, in clinical settings it is often 
the size and configuration of the enlarged ventricles, as well as the location of the choroid 





 Qualitative observations support the hypothesis that by controlling environmental 
cues in the HSCB, factors limiting adhesion are based on the rate of cell transport rather 
than by the rate of cell adsorption.  Thus, the HSCB is quite different from conditions 
modeled in static cell cultures.  These features in combination with data presented here 
indicate that standard cell culturing techniques are not sufficient to model inflammatory 
cell adhesion on catheters used in hydrocephalus.  These data suggest that the flow 
parameters encountered in vivo (and clinically) may have a more influential role in 
astrocyte adhesion than was expected from previous studies. 
 Although use of the HSCB can yield specific data on cell adhesion rate and 
morphology, the model is not without limitations.  Our goal was to obtain a model of 
adhesion with an emphasis on maintenance of appropriate mechanical factors without the 
burden of excessively prolonged exposure times.  The HSCB can accommodate changes 
in cell concentration and exposure time if varying conditions are needed for individual 
experiments.   
 Current studies in our laboratory involve the use of the HSCB in the study of 
influential chemical factors that may alter cellular adhesion.  Variations in cell type and 
protein concentration are being tested to continue to model the foreign body response at 
the catheter–CSF interface at protein concentrations that would mimic the addition of 
blood products in the ventricular system.  As seen clinically [107], the adhesion patterns 
on silicone are highly variable and can appear in clumps.  These patterns were not 






 In this study, the HSCB was used to study how macrophages and astrocytes bind 
to catheters when adhesion is limited by the rate of cell transport, rather than by the rate 
of adsorption like in static cultures.  By manipulating the system so that clinically 
applicable CSF flow rates, pressures, and pulsation frequencies are quantified, we gain a 
physiologic perspective that is not possible in an in vivo animal model where these 
variables are based on the animal's heart rate, choroid plexus size, and level of anesthesia 
[170].  The data in this study revealed that the only mechanical factor to yield a 
significant alteration in astrocyte adhesion was fluid flow, while macrophage adhesion 
was altered by a concurrent change in catheter position and pulsatility.   These data 
suggest that devices used to continuously drain CSF (i.e., shunt catheters and valves) may 
be more susceptible to inflammatory cell adhesion than are devices inserted into the same 




Figure 13  Macrophage attachment to horizontally (A–C) and vertically (D–E) fixed 
catheters at varying flow rates.  Flow rates were 0 mL/min (A, static cultures), 0.25 
mL/min (B and D), and 0.30 mL/min (C and E).  Static cultures (A) have more 
pronounced and extended processes as compared to samples exposed to flow.   In static 
cultures, vertically oriented samples are not included in standard practice and have not, 
therefore, been included in this analysis.  Morphologically, cells exposed to static 
conditions have many more extended processes as compared to cells exposed to flow.   
Actin and vinculin appear either co-localized (yellow) or dissociated (red and green, 
respectively) to depict the cytoskeleton and the focal adhesion contacts of the 
macrophages while DAPI (blue) was used to label the nuclei.   Scale bar denotes 50 μm 






Figure 14 Astrocyte attachment to horizontally (A–C) and vertically (D–E) fixed 
catheters at varying flow rates.  Flow rates were 0 mL/min (A, static cultures), 0.25 
mL/min (B and D), and 0.30 mL/min (C and E).  As compared with static culture (A), 
astrocyte adhesion on horizontally fixed catheters appeared elevated at 0.25 mL/min (B) 
and at 0.3 mL/min (C), although at 0.3 mL/min, clusters of cells were more evident.  
Adhesion on vertically fixed catheters appeared along the length of each analyzed section 
yet there was no clear change in concentration.  Morphologically, individual cells seem to 
be relatively round with only minor evidence of process extension.  GFAP for astrocytes 







Figure 15 The average blue component in macrophage (A) and astrocyte (B) images.   
While there was no statistically significant difference in macrophage adhesion, a trend 
would suggest that adhesion increases with increasing flow rate (and shear stress) when 
samples were held horizontally.   The difference in astrocyte adhesion between the static 
culture (denoted as 0 mL/min) and samples exposed to 0.25 mL/min flow and 0.3 
mL/min, however, is statistically significant as determined using a Kruskal Wallis H 
Test.   In static cultures, vertically oriented samples are not included in standard practice 
and were therefore excluded for this analysis.  No significant differences in adhesion 
were observed when comparing vertically fixed catheters with either cell type.   A sample 






Figure 16 Macrophage attachment to horizontally (A–B) and vertically (C–D) fixed 
catheters at average luminal pressures of -1.66 mmHg (A and C) and 16.43 mmHg (B 






Figure 17 Astrocyte attachment to horizontally (A–B) and vertically (C–D) fixed 
catheters at average luminal pressures of -1.66 mmHg (A and C) and 16.43 mmHg (B 






Figure 18 Analysis of the blue DAPI channel for both macrophages (A) and astrocytes 
(B) revealed no significant difference in adhesion in the presence of low (mean -1.66 
mmHg) or high (mean 16.43 mmHg) pressure as determined using a Kruskal Wallis H 
Test.  Trends between low and high pressure in all groups but the horizontal macrophages 
imply that adhesion increases as the luminal pressure increases.  A sample size of 12 was 






Figure 19 Macrophage attachment to horizontally (A–C) and vertically (D–F) fixed 
catheters at varying pulsation rates: 70 pulses/min (A and D), 100 pulses/min (B and E), 
and 200 pulses/min (C and F).  Clumping of macrophages can be seen under all 






Figure 20  Astrocyte attachment to horizontally (A–C) and vertically (D–F) fixed 
catheters at varying pulsation rates: 70 pulses/min (A and D), 100 pulses/min (B and E), 
and 200 pulses/min (C and F).  The dramatic yet widely variable distribution of cell 
clumping can be observed, for example, when comparing panels D and E.   Scale bar 







Figure 21  Macrophage (A) and astrocyte (B) adhesion dependency on pulsation rate 
acquired using analysis of the blue DAPI channel of the fluorescent images.   No 
statistically significant differences were found between samples as determined using a 
Kruskal Wallis H Test except between macrophage adhesion on horizontal samples at 70 
pulses/min and on vertical samples at 100 pulses/min (P < 0.05).  A sample size of 12 






EFFECTS OF SURFACE WETTABILITY, FLOW, AND PROTEIN 
CONCENTRATION ON MACROPHAGE AND ASTROCYTE  
ADHESION IN AN IN VITRO MODEL OF CENTRAL  
NERVOUS SYSTEM CATHETER OBSTRUCTION2   
 
4.1 Introduction  
Hydrocephalus, a neurological disorder often associated with high intracranial 
pressure (ICP) and expanding cerebral ventricles, is most often treated by implanting a 
catheter (shunt system) into the lateral ventricles to drain excess cerebrospinal fluid 
(CSF).  Shunt systems are made of poly(dimethyl)siloxane (PDMS, silicone) because of 
its high tensile strength, tear resistance, hydrophobicity, and inert nature [75].   In part 
because of the high hydrophobicity (low surface wettability) of PDMS, its use as a 
biomaterial is restricted because interactions between PDMS and the body after 
implantation can include undesired protein adsorption and cell adhesion/scarring [64].   
Protein adsorption and cell and tissue adhesion on PDMS shunt tubing have been 
scrutinized recently because of the extremely high failure rate of shunt systems used to 
treat hydrocephalus [50, 107, 159].   Within 10 years of implantation, 85% of PDMS 
                                                 
2 Reprinted from Journal of Biomedical Materials Research: Part A, accepted manuscript, Harris, CA; 
Resau, JH; Hudson, EA; West, RA; Moon, C; Black, AD; McAllister JP  "Effects of surface wettability, 
flow, and protein concentration on macrophage and astrocyte adhesion in an in vitro model of central 






shunt systems fail [45], and the cause is usually tissue occlusion of the ventricular 
catheter, most often by microglia, macrophages, and astrocytes.  Nevertheless, few 
attempts to manipulate the surface properties of shunt catheters to inhibit inflammatory 
cell binding have been reported.  Further, the published data are contradictory.  Many 
factors may influence these results, including alterations in the environmental conditions 
in which the device is implanted.  Previous findings suggest that flow influences adhesion 
[102], and a broad range of literature suggests that surface chemistry influences cell 
attachment [88, 171]; however, the effect of shunt surface wettability under the flow 
conditions seen in the cerebral ventricles has not been investigated.   We hypothesized 
that adhesion would increase on a less wettable surface and with increasing flow.   
In the medical device industry, the use of hydrophilic surface coatings (with high 
surface wettability) has gained momentum in the past few decades because of their 
potential to inhibit nonspecific protein deposition and cell attachment.  Mechanically, 
CSF bulk flow, flow pulsation rate, and flow-induced shear rate alter cell-surface 
interactions [79, 90, 163, 172], including initial astrocyte binding [140].  Chemically, 
increasing protein concentration has been shown to increase attachment in neuron–glia 
cultures [173].   We hypothesize that an increase in protein concentration will increase 
macrophage and astrocyte attachment.  Using a bioreactor specifically designed to 
simultaneously mimic the bulk flow rate, pulsatile flow rate, flow-induced luminal shear, 
and protein concentration observed in the cerebral ventricles [140], we used surface 
hydroxyl groups to render the surface of PDMS hydrophilic and inhibit initial 





4.2 Materials and Methods 
4.2.1 Macrophage culture and maintenance 
 Mus musculus IC-21 macrophages derived from SV-40 transformed peritoneal 
macrophages with phagocytic properties were obtained from ATCC (Manassas, VA).  
These were originally obtained from a C57BL/6 mouse (ATCC product number TIB-
186) and were chosen primarily because of their mature phenotype[142] and 
characteristic similarity to supraependymal macrophages found bound to CNS implants 
[143].   After rinsing with Dulbecco’s Phosphate Buffered Saline (DPBS, Invitrogen), 
macrophages were cultured in RPMI-1640 medium with 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid HEPES, 1% penicillin-streptomycin (Sigma, St.  Louis, 
MO), 1% GlutaMAX (Invitrogen, Carlsbad, CA ), 1% sodium pyruvate (Invitrogen), and 
10% fetal bovine serum (FBS, Sigma).  Cells were split at 80% confluence and seeded in 
T-75 culture flasks, as observed under an inverted microscope.  Cells were used after 8 
passages following obtainment from ATCC. 
 
 
4.2.2 Astrocyte extraction, isolation, and maintenance 
 Astrocytes were chosen primarily because they bind consistently to ventricular 
catheter explants [49].  Fetal rat astrocytes were extracted using previously described 
methods [140] approved by the Institutional Animal Care and Use Committee.  Briefly, 
minced brain tissue in PBS, 1 mg/mL DNase with manganese, and 1X Trypsin was 
centrifuged, resuspended, and filtered through an 80-μm nylon mesh prior to seeding.  





cytometry and staining techniques separately confirmed the presence of high glial 
fibrillary acidic protein (GFAP) in the dissociated cells.  RPMI-1640 culture medium 
with 25 mM HEPES, 1% penicillin-streptomycin, 1% GlutaMAX, and 10% FBS 
sustained proliferation; the culture was split when confluency reached 80%.  Cells were 
used after 40 passages which could serve as a potential caveat to the study, but GFAP 
expression did not appear to be altered after continued passages (data not shown). 
 
 
4.2.3 Cell detachment for passaging and experimental analysis 
 Similar to previous work completed in our laboratory [140], subsets of 
macrophages and astrocytes were immersed in a low concentration of albumin-rich 
medium (0.5% FBS with an albumin additive) for 24 hours before analysis to mimic both 
the total protein (208.1 mg/L) and the albumin (155 mg/L) concentration of normal CSF 
prior to cell detachment.  A second group of macrophages and astrocytes were immersed 
in medium with a standard protein concentration (10% FBS), since higher, variable 
protein concentrations exist in CSF, especially CSF extracted from patients with 
hydrocephalus [174-175].   
 Macrophages and astrocytes were detached from cell culture flasks using a 5-min 
exposure to 1X TrypLE Express (Invitrogen).   Once macrophages had been immersed in 
the enzyme solution for 5 min, mechanical disruption facilitated removal by striking the 
walls of the flasks sharply.  Viable cells were counted on a hemocytometer using the 
Trypan blue exclusion test and suspended in medium with the low or high protein 





cells/mL (3 × 106 cells total).  The cellular solution was added to either the static culture 
or the bioreactor for testing. 
 
 
4.2.4 Design of static culture systems, cell attachment, and cell viability 
 Macrophages and astrocytes were seeded separately onto silicone surfaces in 6-
well culture plates.  A silicone layer at the bottom of the plates was prepared using the 
Sylgard 184 Silicone Elastomer Curing Agent and Base (Dow Corning, Midland, MI) at a 
ratio of 10:1.  Approximately 1 mL of the de-gassed combined solution was injected into 
each well and allowed to cure at a temperature of 60°C for 4 hours before the wells were 
seeded.  A subset of plates were placed in an oxygen plasma chamber under a pressure of 
200 mTorr and a power of 50 W for 2 min at room temperature.  This process introduced 
hydroxyl groups and removed methyl groups at the surface [176].   After exposure, 
plasma-oxidized PDMS (OH-PDMS) was immediately placed in double-distilled, 
deionized water to temporarily maintain surface wettability.  Samples were used within 
30 min of preparation.  Macrophages and astrocytes in both low- and high-protein 
solutions were seeded separately.  After a 20-hour exposure period at 37°C, cells were 
fixed in 4% (w/v) paraformaldehyde for 2 hours and visualized with immunofluorescence 
and analyzed with confocal microscopy.   
 
 
4.2.5 Design of the hydrocephalus shunt catheter bioreactor and cell viability 
 A previously published method established by our group to test adhesion on 





uses a three-channel peristaltic pump (Watson-Marlow 401U/DM3, Cornwall, England) 
to propel cells through catheter tubing to mimic CSF flow.   Since cell adhesion can be 
measured with a user-defined (and physiological) flow rate, the model can be 
manipulated to determine the effect of surface modifications in flow conditions similar to 
those encountered by a clinically implanted shunt system.   A flow rate of 0.3 mL/min 
and pulsation rate of 280 pulses/min were used to imitate pulsatile, ventricular CSF flow 
under normal conditions [11].   To test the effects of altering the surface wettability with 
minimal alterations in surface chemistry and topography, hydroxyl groups were 
introduced onto both external and internal surfaces of medical-grade shunt tubing (native 
PDMS, Neurosurgery Division of Medtronic, Goleta, CA) by placing samples into an 
oxygen plasma chamber similarly to samples used in the static culture experiments.   
Adhesion was measured after a 20-hour exposure period.  This time period for attachment 
was chosen because (a) the concentration of cells in solution approaches zero after 20 
hours of exposure to the system, and (b) the first 20 hours captures initiation of the acute 
inflammatory stage during which inflammatory cell recruitment begins in vivo [64].   
 
 
4.2.6 Surface characterization via static water contact angle measurements 
 To confirm that surface wettability was increased by our method, a subset of 
native PDMS and OH-PDMS groups was characterized using water contact angle 
measurements.  Contact angles were obtained using a contact angle goniometer using the 





measured after 20-hour exposure to approximately 20 μL of double-distilled, deionized 
water.     
 
 
4.2.7 Fluorescent staining procedure  
 Detailed procedures on cell staining on PDMS can be found in previously 
published reports from our laboratory [140].   Briefly, astrocytes and macrophages bound 
to PDMS tubing were immersed in 4% (w/v) paraformaldehyde in PBS for two hours at 
ambient temperature.  Fifteen minutes of exposure to anhydrous methyl alcohol was used 
to permeabilize the macrophages.   Each sample was rinsed and stored overnight at 4°C 
in 0.1 M PBS.   All samples were cut longitudinally to expose the lumen for fluorescent 
staining.   Samples were washed in 0.1% Triton X in 0.1 M PBS to assure cell 
permeabilization.  Macrophages were double stained using 1:300 polyclonal sheep anti-
actin (Chemicon) in 0.1 M PBS followed by a 1:100 Cy3-conjugated polyclonal 
secondary antibody (Chemicon) in 0.1 M PBS to label macrophage actin filaments and 
1:300 monoclonal mouse anti-vinculin (Chemicon) in 0.1 M PBS observed with 1:100 
FITC-labeled polyclonal goat anti-mouse IgG (H+L) (Chemicon) in 0.1 M PBS to 
identify focal adhesion plaques.  Tubing with bound macrophages was also 
counterstained with the nuclear dye 4',6-diamidino-2-phenylindole (DAPI) diluted from 1 
mg/mL stock to 1:1000 in 0.1 M PBS using established methods.  Astrocytes were 
labeled with monoclonal mouse anti-GFAP (Chemicon) fluorescently labeled with 
polyclonal goat anti-mouse IgG (H+L) followed by counterstaining of the nuclei using 





4.2.8 Analysis of cell attachment  
 After fluorescent staining, a Zeiss 510 confocal microscope was used to acquire 
spectral epifluorescent images, and Zeiss LSM image analysis software was used for 
characterizations.  Two random spots along each tube half and on each static culture 
sample were analyzed at 20X magnification (n=12, where tubing halves were grouped 
and the number of spots equal across groups).  Attachment was quantified by the 
intensity of the blue (DAPI) channel of the confocal images.  The average blue 
component in digital Red-Green-Blue (dRGB) space was determined using the DAPI 
intensity.  Data were reported as a percent of total light emission, with 255 representing 
brightest light emission. 
 
 
4.2.9 Statistical analyses 
The Anderson Darling normality test was used to reveal whether data sets 
followed a normal distribution.  The Bartlett's test was used to determine the degree of 
homoscedasticity within data sets.  Parametric results were compared using a two-tailed 
Student's t-test with α = 0.05; in the case where two dependent hypotheses were tested 
simultaneously, the Bonferroni correction set significance at 0.025.   Nonparametric 
results were compared using either a two-tailed Mann-Whitney U Test or the Kruskal-
Wallis H Test with a confidence interval of 0.95 (α = 0.05).  In the cases where the 
Kruskal-Wallis H Test was used, an unplanned comparison of mean ranks test was 








4.3.1 Water contact angle 
 Native PDMS had advancing and receding water contact angles of 105.58 ± 5.38° 
and 71.34 ± 7.88°, respectively.  Oxidized PDMS exhibited advancing and receding 
water contact angles of 27.03 ± 3.74° and 5.00 ± 6.00°, respectively.  The advancing and 
receding water contact angles of PDMS were significantly different than those of OH-
PDMS (P < 0.01).   
 
 
4.3.2 Macrophage attachment 
 As is shown in Table 7 and Figure 22, macrophage binding was generally 
inhibited on OH-PDMS.  Adhesion (P < 0.05) on OH-PDMS was significantly lower 
than on PDMS under flow conditions independent of the solution’s protein concentration.  
Flow appeared to increase macrophage adhesion in all cases except when a high-protein 
solution was used in combination with OH-PDMS.  Protein concentration by itself did 
not have a significant impact on macrophage attachment, but a trend indicated that a 
high-protein concentration in solution increased adhesion on PDMS but not on OH-
PDMS.  Statistical significance (P < 0.05) was seen between: (1) adhesion in low protein 
and flow on PDMS versus adhesion in low protein and flow on OH-PDMS; (2) adhesion 
in low protein and flow on PDMS versus adhesion in high protein and flow on OH-
PDMS; (3) adhesion in high protein and static culture on PDMS versus adhesion in high 
protein and flow on OH-PDMS; (4) adhesion in high protein and flow on PDMS versus 





adhesion would increase dependent on a less wettable surface and increasing flow was 
incorrect, although a nonsignificant trend did imply this relationship. 
 
 
4.3.3 Astrocyte attachment 
 The data suggest that surface hydroxyl groups on PDMS inhibit astrocyte 
adhesion in most cases (Table 7 and Figure 23), although this trend was not statistically 
significant when analyzed using least significant difference in mean ranks.  Flow 
enhanced adhesion in every case.  The difference between the static and flow conditions 
was significant (P < 0.05) when adhesion was analyzed on PDMS surfaces under high-
protein conditions.  A variance in protein concentration within the astrocyte-suspended 
solution appeared to increase the difference between static and fluidic cultures but did not 
significantly alter adhesion when all other conditions were held constant.  Our hypothesis 
that astrocyte adhesion would increase dependent on a less wettable surface and 
increasing flow was incorrect, although a nonsignificant trend did imply this relationship. 
 
 
4.3.4 Comparison of macrophage and astrocyte attachment 
 A statistically significant difference (P < 0.05) in attachment of macrophages and 
astrocytes was found under static conditions and low- and high-protein solutions on 
PDMS and in high-protein solutions on OH-PDMS.  In these cases, macrophage adhesion 
was greater than astrocyte adhesion except on PDMS surfaces when a low-protein 
solution was used.  In this specific case, astrocyte adhesion was greater than macrophage 





adhesion was significantly greater than macrophage adhesion (P < 0.05), independent of 
surface type.  Under fluidic conditions and a low-protein solution, the difference between 
macrophage and astrocyte adhesion on PDMS and OH-PDMS was insignificant (P = 0.22 
and 0.09, respectively).   
 
 
4.3.5 Cell morphology 
Representative confocal images of adherent cells on either PDMS or OH-PDMS 
under static or fluidic conditions and in a high- or low-protein solution can be seen in 
Figure 24.  It is important to note that the concentration of cells in these images cannot be 
compared between static and fluidic conditions without normalizing the area.  
Macrophages and astrocytes adherent on either the PDMS or the OH-PDMS substrate in 
the flow system appeared to have a rounded morphology.  Cellular processes did not 
appear extended.  Clumping of astrocytes was more exaggerated on OH-PDMS under 
high-protein conditions in static and fluidic culture.  Double staining of adherent 
macrophages provided means for analysis of stress fibers (actin) and point-wise 
attachment using focal adhesions (vinculin).  Under static culture conditions on PDMS, 
macrophages exhibited extended processes, but these were less pronounced on OH-





4.4 Discussion  
  In an effort to understand how surface modifications may alter macrophage and 
astrocyte adhesion on catheters used to treat hydrocephalus, we examined how the 
addition of surface hydroxyl groups by plasma oxidation altered adhesion under various 
adaptations to flow and protein concentrations.  We observed that (a) the addition of 
surface hydroxyl groups inhibited adhesion in most cases but increased adhesion in some 
cases under static conditions, (b) flow enhanced adhesion with one exception being a 
decrease in macrophage adhesion on oxidized surfaces under high protein conditions, and 
(c) adhesion increased with increasing protein concentration except in two cases 
(macrophage adhesion on oxidized surfaces under flow and astrocyte adhesion on PDMS 
in static conditions decreased with increasing protein concentration).  It was apparent that 
the degree to which these factors played a role in adhesion varied depending on the cell 
type.  Surface hydroxyl groups had an inhibitory effect on macrophage binding that was 
generally more pronounced than the effect of flow or protein concentration under the 
same conditions.  With astrocytes, flow increased binding, and the effect was more 
pronounced than the effect of surface hydroxyl groups or protein concentration under the 
same conditions.  To inhibit both macrophage and astrocyte attachment on shunt systems 
used in hydrocephalus, it becomes obvious that both the surface chemistry and the flow 
are important.  Future work should incorporate surfaces treatments with added hydroxyl 
groups as well as modulation of flow through the catheter by adapting the architecture of 





Studies of shunt systems are behind those of other devices, including vascular 
prostheses, heart valves, intraocular implants, hip and joint prostheses, and contact lenses 
[87], which have already extensively explored material modifications that may inhibit 
cell attachment.  On a hydrophobic surface like PDMS, a biological response can be 
initiated through an entropic drive for the hydrophobic moieties of proteins in solution to 
bind onto the implant.  In most conditions, this response will be stronger on hydrophobic 
materials, inducing more cellular activation and spreading than on hydrophilic materials 
[83].   This response favors tailoring the surface chemistry of biomaterials like PDMS 
[77-79].   However, the degree of cell attachment is multifactorial and is also dependent 
on surface-available functional groups [177], roughness [89, 178-179], charge [89], and 
the environment in which the material is implanted.  We chose to study differences in 
initial cell adhesion between native and plasma-oxidized PDMS to test a wide range of 
wettability (hydrophobic and hydrophilic extremes) with minimal topographical changes 
[180].    
 
 
4.4.1 The effect of plasma oxidation on macrophage  
and astrocyte attachment 
 
 Our results indicate that the addition of surface hydroxyl groups reduces adhesion 
of macrophages (significantly) and astrocytes (insignificantly) in the acute term under 
physiological flow, which correlates to data found on modified microfluidic devices [79, 
90].   These effects may be due to the fact that surface functionality strongly influences 
cell integrin binding and specificity through focal adhesion assembly [181].   





bodies.  Especially in cases of shunt failure, macrophages/microglia have been found 
focally attached to shunt systems [107, 115].   Macrophages bound to a foreign body in 
the central nervous system (like the shunt system) act as a precursor to the formation of 
an astrocytic capsule around the implant [182], so early resolution of the response is 
ideal.   
The addition of surface hydroxyl groups to PDMS surfaces via plasma oxidation 
did not significantly reduce astrocyte adhesion.  Other reports have suggested that the 
phenotype, morphology, and extracellular matrix protein requirements of fibroblasts 
adherent to a biomaterial are distinct from adherent monocyte/macrophage cells [183].   
There may be a similar heterogeneity between the attachment requirements for astrocytes 
and macrophages.  Both cell types bind via integrin-mediated interactions with adsorbed 
protein ligands, but the specific interactions are cell type dependent.  While these 
connections can control the function of the cell, which may alter the degree in which the 
cell moves, proliferates, rearranges its cytoskeleton, or survives [184], it may be simply 
that attachment of astrocytic end feet are less permissive to changes in the adsorbed 
protein layer.   
 
 
4.4.2 The effect of flow on macrophage and astrocyte attachment 
The introduction of flow at a flow rate of 0.3 mL/min, the calculated clinical 
production rate of cerebrospinal fluid [11], increased adhesion of macrophages and 
astrocytes.  The change from a static to a flow environment had a striking (and 





attachment was apparent but not significant.  An important  limitation to these results, 
however, is the geometrical dissimilarity between the static and fluidic cultures.   
Although calculations were made to insure that the total surface area to which cells were 
exposed and the cell densities were equivalent, future work should address this issue by 
altering the static cultures such that cells are seeded directly into catheter lumina.  
Previous work by our group has shown that flow increases astrocyte adhesion 
significantly whereas pulsation rate and pressure do not.  Together, these studies reveal 
that flow rate had a stronger influence on astrocyte adhesion in the short term than flow 
pulsation rate, pressure, protein concentration, and the addition of surface hydroxyl 
groups on PDMS samples.  Most likely, material surface properties dictate protein 
adsorption and cell adhesion [88], but these properties are also dependent on surrounding 
conditions.  Flow probably modifies receptor-ligand chemical kinetic rate between the 
bound and unbound state, causing flow-enhanced cell tethering [102].   Mechanical stress 
has been shown to manipulate the strength of cell surface integrins [166].   It is possible 
that the difference in response to flow from the macrophage and astrocyte is dependent 
on the difference in the initial strength or flow-effected strength of the cell's integrins.  
The finding that flow exacerbates adhesion may also be dependent on the shear rate at the 
shunt catheter interface.  This dependency has been shown with other cell types [102, 
172].   Thus, alterations to the catheter dimensions that would alter the flow-induced 






 Classically, there has been a disconnect between results attained from in vitro 
modeling and in vivo implantation.  Modifications to the surface wettability of recording 
electrodes have had a dramatic effect in vitro but a minimal effect on the surrounding 
cortical foreign body response in vivo [185].   One reason for this may be that the unique 
protein expression patterns of cultured cells compared to in vivo cells influence adhesion 
and adhesion rate.   This is an obvious limitation to in vitro work that has not been 
eliminated in this study.   Another reason for an in vitro - in vivo disconnect is that many 
in vitro models fail to incorporate pertinent mechanical cues presented in vivo.  Here, we 
attempt to minimize these differences by incorporating pulsatile flow and found that 
macrophage adhesion was generally greater than astrocyte adhesion under static 
conditions but the opposite was true under fluidic conditions (Table 1).  These data 
emphasize the need to study adhesion using a test bed that includes flow.   
 The results concerning the effect of flow are quite interesting for hydrocephalus 
research because of the relatively unique environment in which the shunt system is 
implanted.  CSF is produced actively and passively as a blood filtrate from the choroid 
plexus and from the parenchyma [16].   Changes in cerebral pulsatility, cerebral blood 
flow, intracranial pressure, and body movement, however, can cause the outflow to be 
nonconstant over time.  For instance, patients with normal pressure hydrocephalus are 
prone to a decrease in CSF production [186], as are patients with chronic hydrocephalus 
[15].   Slower or static CSF flow allows toxins and amyloid to accumulate in the brain, 





with less flow may be at a lower risk for inflammation-derived occlusion because of the 
decrease in macrophage and astrocyte attachment in static conditions observed here.   
 
 
4.4.3 Effect of protein concentration on macrophage  
and astrocyte attachment 
 
 Cell culture medium protein concentration was manipulated in an effort to 
understand how changes in CSF protein concentration may affect inflammatory cell 
adhesion on native and oxidized PDMS in the treatment of hydrocephalus.  A recent 
study showed that 23% of shunt systems that were removed because of obstruction or 
infection were from patients with protein concentration greater than 1.0 g/L [174].   
Generally, the high protein concentration enhanced cell adhesion under fluidic 
conditions, but this trend was not significant.  Using PDMS catheters, extrapolation of 
these acute patterns suggests that patients with a higher concentration of CSF protein may 
be more likely to have an inflammation-related obstruction.  Clinically, it is more likely 
for patients with abnormal CSF (high protein, many cells) to have an obstruction [191], 
and although higher CSF protein content by itself does not cause proteins to obstruct 
catheters [175], an increasing protein concentration may influence cell attachment.  This 
relationship has been shown using culture media where serum influences macrophage 
[183] and neural-glial [173] adhesion in vitro.  Because altering the total protein and 
albumin concentrations in culture media is not identical to alterations in the protein 
content of CSF, future studies will attempt to compare these results with those obtained 






4.4.4 Impact of conditions on macrophage and astrocyte morphology 
 Because the morphology varied depending on the presence or lack of flow, using 
a pulsatile flow system like the bioreactor seems essential in mimicking some of the 
mechanical factors seen in the ventricular cavity in vivo.  The morphology of the 
macrophages changed dramatically with the addition of flow.  Under static culture 
conditions on PDMS, macrophages exhibited extended processes, but these were less 
pronounced on OH-PDMS, especially when a low concentration of protein was used.  
Under fluidic conditions, these extended processes were not visible.  Actin without 
vinculin termination may infer cell perturbation by mechanical shear since shear can 
affect actin and vinculin distribution [192].   The minimal filopodial extension can be 
interpreted as the cell's lack of effort to spread under fluidic conditions, or the initiation 
of cell necrosis.  The rounded morphology of astrocytes under both static and fluidic 
conditions might also indicate that the acute 20-hour incubation period was not long 
enough for cells to extend their processes.  Clumping of astrocytes with curious 
dislocation between the GFAP and cell nuclei may be indicative of nonpermissive 
surfaces.  Previous reports have indicated that astrocytes bound to CNS implants after 8 
days of implantation are hypertrophied [182].   After an acute 20-hour exposure to our 
flow system, astrocytes did not appear enlarged compared with the static culture.  Future 
work prolonging the incubation time of these experiments may allow a comparison 








This study is one of the first that attempts to examine the relationship between 
surface chemistry and cell attachment in a bioreactor that mimics the pulsatile flow 
mechanics of the cranial cavity.  Plasma-oxidized PDMS inhibited macrophage binding 
compared with native PDMS, while flow significantly exacerbated astrocyte but not 
macrophage adhesion.  The quantity of astrocyte adhesion was greater than macrophage 
adhesion under fluidic conditions but generally less than macrophage adhesion under 
static conditions.  Thus, to inhibit both macrophage and astrocyte attachment on shunt 
systems used in hydrocephalus, both the surface chemistry and the flow rate should be 
modified by long-term surface modifications and alterations in catheter architecture.  
Surprisingly, protein concentration by itself did not have a significant impact on 
attachment, although a trend toward increased attachment with greater total protein 
concentration was apparent.  The morphology of adherent cells was affected by flow, but 
this effect was seen more with macrophages than astrocytes.  
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Macrophage Static Conditions 1.07 ± 0.19 3.16 ± 0.69 1.20 ± 0.18 1.26 ± 0.14 
Macrophage Fluidic Conditions 3.94 ± 0.25 4.07 ± 0.67 1.52 ± 0.40 0.46 ± 0.31 
Astrocyte Static Conditions 1.90 ± 0.08 0.27 ± 0.10 0.79 ± 0.10 0.68 ± 0.18 







Figure 22 The average percentage of blue in dRGB space as determined by analysis of 
macrophage DAPI intensity.  Although each tested component had an impact on 
adhesion, the most dramatic difference was caused by the addition of surface hydroxyl 
groups (OH-PDMS).   Statistical significance was determined using a Kruskal Wallis H 
Test.   An asterisk (*) denotes a significant difference (P < 0.05) in adhesion compared to 
adhesion in low protein and flow on PDMS; α denotes a significant difference (P < 0.05) 
in adhesion compared to adhesion in high protein and flow on OH-PDMS.   A sample 






Figure 23 The average percentage of blue in dRGB space as determined by analysis of 
astrocyte DAPI intensity.  A trend in intensity suggests that flow, protein concentration, 
and the addition of surface hydroxyl groups altered adhesion, but flow had the most 
apparent impact on astrocytes adhesion.  Significance is denoted by an asterisk where * 
indicates significance compared to adhesion in high protein and static conditions on 
PDMS as determined using a Kruskal Wallis H Test.  A sample size of 12 was used for 






Figure 24  Macrophage (A-H) and astrocyte (I-P) attachment on PDMS and OH-PDMS 
under the indicated conditions.  Morphologically, macrophages appeared to have 
extended processes in static conditions but retracted processes in flow conditions 
(compare A and E, C and G, and D and H).  Cellular processes of adherent astrocytes did 
not appear extended.  Astrocytes appeared to clump on OH-PDMS under static or flow 
conditions (compare J and N and L and P).  Actin has been fluorescently stained in red 
(macrophages), vinculin in green (macrophages), GFAP in green (astrocytes), and DAPI 






REDUCTION OF PROTEIN ADSORPTION AND MACROPHAGE AND 
ASTROCYTE ADHESION ON VENTRICULAR CATHETERS BY  
POLYETHYLENE GLYCOL AND N-ACETYL-L-CYSTEINE3  
 
5.1 Introduction  
 Hydrocephalus, a condition resulting from an imbalance between cerebrospinal 
fluid (CSF) production and absorption, is a chronic disorder affecting 1 in 500 
individuals, particularly children.  In most cases of hydrocephalus the cerebral ventricles 
expand and intracranial pressure (ICP) rises dramatically.  Implanting a 
poly(dimethyl)siloxane (PDMS) catheter into the lateral ventricles allows drainage of 
CSF from the cranial cavity, lowering the ICP to safe levels.  While this type of shunt 
treatment is usually effective temporarily, revisions are often necessary as current shunt 
systems are plagued with occlusion-related failure.  In a clinical study intended to 
decipher methods of failure, 61.7% of the 344 patients undergoing first-time shunt 
placements had failure of the shunt due to obstruction [42].  Previous results using 
scanning electron microscopy  and histological analysis [44, 49, 108, 116] show that a 
                                                 
3 From Journal of Biomedical Materials Research: Part A, submitted manuscript, Harris, CA; Resau, JH; 
Hudson, EA; West, RA; Moon, C; Black, AD; McAllister JP  "Reduction of protein adsorption and 







high percentage of obstructions contain choroid plexus, microglia/macrophages, and 
astrocyte cells.   
 There has been a tremendous effort to inhibit protein adsorption and subsequent 
cell attachment on medical devices [63-64, 85, 193-194] that may elicit responses such as 
shunt obstruction.  Surface treatments are often chosen based on the application of the 
medical device, the desired reaction, and the underlying material.  One surface treatment 
that has shown great potential to reduce protein adsorption on many medical devices is 
polyethylene glycol (PEG) [195-198].  For oral and topical applications, polyethylene 
oxide has been approved by the U.S.  Food and Drug Administration; has been 
investigated as a medical device coating; has been used as a drug carrier; has shown 
applicability in tissue engineering [199-200], and has been applied to nanotechnology 
[201].  PEG is a nondegradable hydrophilic polymer and, depending on the deposition 
method when used as a coating, is stable over time.  PEG inhibits proteins with and 
without cell adhesive ligands [202].  PEG has been shown to inhibit cell adhesion [195], 
probably because the adsorbed protein layer is critical for subsequent interactions with a 
variety of cell types.   
 The mechanisms of inhibition by PEG-modified surfaces depend upon PEG 
surface density and molecular weight [78].  Often, a decrease in molecular weight of 
coatings correlates with an increase in surface grafting density and an increase in protein 
adsorption [195, 203-204].  We hypothesized that these relationships would continue to 





would be inhibited more by high-molecular-weight PEG than by the lower-molecular-
weight PEG in a fluidic environment similar to that seen in the cerebral ventricles.   
 A pharmacologic agent that has recently been used as a surface modifier  is N-
acetyl-L-cysteine (NAC).  NAC is a hydrophilic pharmacologic agent used most often to 
inhibit mucous overproduction by hydrolyzing glycosaminoglycans through the 
breakdown of disulfide bonds.  Their distinctive sulfhydryl moieties can also interact 
with and terminate reactive oxygen species in its conversion to glutathione, making NAC 
a useful supplementary antidote to oxidative stress.  NAC sulfhydryl groups can 
characteristically and nonspecifically reduce cytoplasmic proteins by converting cystine 
to cysteine.  NAC has been successfully bound to stainless steel, and previous data 
suggest that these coated surfaces deter bacterial biofilm formation [205].  Because cell 
propensity to bind, grow, differentiate, and proliferate on biomaterials is highly 
dependent on specific interactions of the adsorbed protein layer ligands and 
transmembrane integrins, we chose to investigate whether PDMS modified with NAC via 
adsorption and covalent techniques would inhibit protein adsorption.  We hypothesized 
that NAC would inhibit protein adsorption and macrophage and astrocyte adhesion in a 
fluidic environment that mimics flow in the cerebral ventricles. 
In this work, we tested PEG and NAC surface modifications using our previously 
published in vitro model incorporating pulsatile flow because it mimics many dynamics 
of the cerebral ventricles [140].  Because protein adsorption provides a means for 





the protein attachment inhibitor molecule PEG and the disulfide reducer N-acetyl-L-
cysteine (NAC) to inhibit protein adsorption and cell attachment.  
 
5.2 Materials and Methods 
5.2.1 Fabrication of PEG and NAC modified PDMS     
 Medical grade silicone tubing (PDMS) was obtained from Dow Corning 
(Midland, MI).  A subset of tubing used for each modification type was placed in an O2 
Plasmod plasma chamber and held at 200 mTorr to convert surface methyl groups to 
surface hydroxyl groups, forming oxidized PDMS (OH-PDMS).   
 PEG604 (2-(methoxy(polyethyleneoxy)propyl)trichlorosilane, Gelest, Covington, 
KY, 472–604 Da) was immobilized on OH-PDMS by forming an attachment between the 
silane and the PDMS surface hydroxyl groups by way of chemical vapor deposition.  To 
achieve this, 3 mL of 10% (v/v) of PEG-Cl3 in deionized water was added to a 50-mL 
Erlenmeyer flask.  Tubes were suspended over the flask and covered using a PDMS sheet 
and electrical tape.  The reaction container was set on a hot plate for 12 hours at 95°C 
similar to previously established methods [206].  Tubes were then removed and washed 
in 0.1 M phosphate-buffered saline (PBS). 
 PEG5K (5000 Da) was immobilized on PDMS using methods similar to those 
described by Chen and colleagues [207].  OH-PDMS tubes were immersed in a 40% w/v 
solution of  PEG methyl ether (Sigma-Aldrich, St.  Louis, MO) in isopropanol.  A 
platinum catalyst (platinum–divinyltetramethyldisiloxane complex) was added at a ratio 





15 hours at room temperature on a rotator before the tubes were removed and washed in 
0.1 M PBS. 
 NAC was immobilized onto the surface of OH-modified PDMS using two 
methods.  In the first method, OH-PDMS was immersed into an NAC-rich solution (4 
mg/mL in deionized water) for 24 hours at room temperature to induce physical 
adsorption (NAC-OH-PDMS) similar to studies where NAC was used to modify the 
surface of stainless steel [205].  In the second method, OH-PDMS was immersed into an 
NAC-rich solution (4 mg/mL in deionized water) with N-hydroxysuccinimide (NHS) and 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) (EDC) additives each at 2.5 mg/mL to 
activate the carboxylic acid groups of NAC and enhance coupling of the carboxylic acid 
groups to the hydroxyl groups.  The pH of the NAC-rich solution ranged from 2.25 to 
2.29 and when EDC and NHS were added, 2.84 to 2.86.  In a subset of samples, the pH 
was increased to 6.0 using 40X PBS to encourage attachment.  However, attachment in 




5.2.2 Surface characterization      
 Water contact angles (the angle created at a solid surface interface from 
interactions with water and gas) and X-ray photoelectron spectroscopy (XPS) were used 
to characterize the surface treatments in this study.  Contact angles of PDMS, OH-PDMS, 
and NAC-OH-PDMS were obtained using a contact angle goniometer.  Advancing and 





distilled deionized water.  Data on the chemical composition for all samples were attained 
from the National ESCA and Surface Analysis Center for Biomedical Problems 
(NESAC/BIO) (n=3 with 3 random spots collected per sample).  XPS spectra were taken 
on a Surface Science Instruments S-probe spectrometer equipped with a mono-
chromatized Al Kα X-ray and a low-energy electron flood gun.  The pressure in the 
chamber during acquisition was less than 5E-9 Torr.  Pass energy was 150 eV and 50 eV 
for survey spectra and high-resolution scans, respectively.  The take-off angle was set at 
55°, correlating with a 50 Å sampling depth.  Elemental composition calculations were 
made using the Service Physics ESCAVB Graphics Viewer.   Three spots were measured 
on each sample, and a minimum of three samples were used for analysis. 
 
 
5.2.3 Modification stability 
 To determine whether the PEG and NAC modifications remained bound to the 
PDMS over time, a soak test was performed where samples were soaked in deionized 
water for 30 days at room temperature.  Progressive water contact angles were taken 
using the contact angle goniometer over this time course.   
 Because of the novelty of NAC coatings on PDMS, a second method was used to 
measure the stability of the coatings.  A subset of NAC-OH-PDMS and NAC/EDC/NHS-
OH-PDMS samples was immersed in 0.1 M PBS.  Release of NAC into the PBS solution 
was measured using the A280 assay at 260 and 280 nm on a ND-1000 NanoDrop 





previous analysis of NAC absorbance spectra, NAC peak absorbance is approximately 
260 nm.   
 
 
5.2.4 Protein adsorption assay 
 To determine the effect of PEG and NAC modifications on protein adsorption, 
samples were exposed to a flowing protein solution at 0.3 mL/min and 37° for 20 hours.  
The solution was composed of an equal percent of 100 mg/L fibronectin (Fn, a 
mammalian extracellular matrix glycoprotein present in CSF that, when adsorbed, can 
encourage cell attachment [208]) and 400 mg/L albumin (Alb, a protein nonfacilitative to 
mammalian cell adhesion present in CSF) similar to previously established methods 
[209].  PDMS and oxidized PDMS (OH-PDMS) controls were also exposed to the 
flowing protein solution for comparison with modified samples.   Following exposure, 
samples were processed for immunofluorescent staining using 4% (w/v) 
paraformaldehyde in PBS for two hours.  Samples were immediately rinsed and stored in 
0.1 M PBS overnight at 4°C.  Tubing was cut longitudinally to expose the lumen.  
Samples were then batch stained with polyclonal rabbit anti-bovine fibronectin 
(Cedarlane Labs, Burlington, Ontario, CA) and polyclonal goat anti-rabbit IgG 
conjugated with tetramethyl rhodamine isothiocyanate (TRITC) (Santa Cruz 
Biotechnology, Santa Cruz, CA) to label fibronectin, and polyclonal sheep anti-bovine 
albumin conjugated with FITC (Bethyl Labs, Montgomery, TX) to label albumin.  
Confocal microscopy was performed using a FV1000-XY Confocal Olympus IX81 





intensities.  Data for each condition (n=3) were pooled, a stained negative control was 
subtracted, and data were analyzed for statistical significance. 
 
 
5.2.5 Macrophage and astrocyte culture 
 To determine the degree of adhesion of macrophages and astrocytes, Mus 
musculus IC-21 macrophages and primary rat astrocytes were obtained as described 
previously [140, 210].  Macrophages were cultured in RPMI-1640 with 25 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1% penicillin–streptomycin 
(Sigma, St.  Louis, MO), 1% GlutaMAX (Sigma, St.  Louis, MO), 1% sodium pyruvate 
(Invitrogen, Carlsbad, CA), and 10% fetal bovine serum (FBS, Sigma, St.  Louis, MO); 
astrocytes were cultured in an identical medium without the addition of sodium pyruvate.  
Cells were split at 80% confluence and seeded in T-75 Culture Flasks (ISC Bioexpress, 
Kaysville, UT).   
 Twenty-four hours before cell passaging for experimental analysis, cells were 
soaked in a low concentration of albumin-rich medium to acclimatize them to the total 
protein (208.1 mg/L) and albumin concentration (155 mg/L) of normal CSF.  Cells were 
removed after several washing steps with noncationic Dulbecco's Phosphate Buffer 
Solution (DPBS, Invitrogen, Carlsbad, CA) by a 5-min exposure to 1X TrypLE Express 
(Invitrogen, Carlsbad, CA) at 37°C.  Macrophage agitation by mechanical perturbation 
guaranteed suspension.  Cells were washed and resuspended through centrifugation at 
1200 rpm for 10 min in RPMI-1640.  Using the trypan blue exclusion test, viable cells 





concentration of 4.615E4 cells/ml to equal 3E6 cells total.  The concentration of cells 
coincided with similar studies of catheter obstruction [133].   
 
 
5.2.6 Hydrocephalus shunt catheter bioreactor setup 
 Our previously published in vitro model developed to study cellular adhesion 
under pulsatile flow conditions that mimic those of the cerebral ventricles was used in 
this study [140].  Suspended cells were propelled through this pulsatile flow system and 
through the PDMS (or modified PDMS) sample tubing at 0.3 mL/min with a pulsation 
rate of 100 pulses/min for 20 hours.  Following exposure, PDMS or modified PDMS 
tubing was removed and immediately placed in fixative (4% paraformaldehyde).  
Samples were then longitudinally cut to expose the tubing lumen and the attached cells. 
 Immunofluorescence was used to identify the cell concentration and morphology 
of the attached cells using actin (a major protein of the cytoskeleton), vinculin (a 
cytoskeletal focal adhesion protein at the intracellular face of the plasma membrane that 
is one of the major mediators linking actin to integrins to permit cell 
anchorage/spreading), and cell nuclei staining for macrophages and glial fibrillary acidic 
protein (GFAP) and nuclei staining for astrocytes.  Macrophages bound and fixed to 
PDMS samples were permeabilized in anhydrous methyl alcohol for 15 min.  Tubing 
halves were then batch stained with 1:300 polyclonal sheep anti-actin (Chemicon, 
Temecula, CA) identified with 1:100 Cy3-conjugated polyclonal secondary antibody 
(Chemicon).  Macrophage focal adhesions were identified using 1:300 monoclonal 





H+L (Chemicon).  Astrocytes attached to PDMS or modified PDMS tubing were stained 
with 1:300 monoclonal mouse anti-GFAP (Chemicon) and observed using 1:100 
polyclonal goat anti-mouse IgG H+L (Chemicon).  All tubing was counterstained with 
the nuclear dye 4',6-diamidino-2-phenylindole (DAPI). 
 
 
5.2.7 Imaging and data collection 
 PEG- and NAC-modified samples were compared with PDMS and OH-PDMS 
controls using a Zeiss 510 microscope to obtain spectral epifluorescent images.  Zeiss 
LSM image analysis software was used for characterizations.  Quantitative analysis of the 
percent intensity of DAPI was attained (n=12 with 2 random spots analyzed per tube half, 
Neurolucida, Micro Bright Field, Williston, VT) by analyzing the blue component of 
each image in digital Red-Green-Blue (dRGB) space and reporting it as a percent of total 
light emission, with 255 representing brightest light emission.  For each sample, 
background intensities were subtracted.   
 
 
5.2.8 Statistical analysis 
 The Anderson-Darling normality test was used to determine data normalcy.  
Parametric results were examined using a one-way analysis of variance with α set at 0.05 
followed by a post-hoc Scheffe test.  Nonparametric results were compared using the 
Kruskal Wallis H test followed by a least significance difference in mean ranks test with 








5.3.1 Generation and analysis PEG and NAC modified PDMS 
 Increased wettability and decreased water contact angle compared with the PDMS 
control were clearly evident immediately after modification of PEG and NAC using all 
methods (Figure 25).  Fluctuation between the advancing and receding contact angles 
implies either some surface non-uniformity, particulate on the measured surface, or 
inadequate measuring technique.  The stability of PEG and NAC appeared relatively 
constant, with no advancing contact angle reaching the advancing contact angle for 
PDMS (104.23±1.02°) after 30 days (Figure 26).  At 30 days, the advancing water 
contact angle of PDMS was significantly greater than those of all modified samples, 
PEG604 was greater than PEG5K, and NAC was greater than NAC/EDC/NHS (P<0.05).   
 We measured the release of NAC by measuring the decay of the 260-nm peak 
over time.  The additive level of NAC released over time from NAC/EDC/NHS-OH-
PDMS was considerably higher than that of NAC-OH-PDMS and plateaued near 4.8 
absorbance units/mL (Figure 27).  NAC-OH-PDMS did not appear to release NAC.  
After three days, the difference in inferred NAC release between NAC/EDC/NHS-OH-
PDMS and NAC-OH-PDMS was significant (P<0.05).  No peaks were found at 280 nm.   
 XPS was performed with an approximate depth of 50 Å to obtain surface 
characterization.  Low-resolution XPS results are shown in Table 8, and high-resolution 
results are shown in Table 9.  A presence of PEG was evident from a significant (P<0.05) 
increase in O 1s in both PEG604 and PEG5K samples, a significant decrease in C 1s in 





respectively).  The C 1s spectra of these samples revealed a peak at approximately 286.4 
eV indicative of a C-O species that was not seen in the PDMS controls.  This peak 
represented a greater percent of the C 1s spectra for the PEG604 sample, but this 
difference was not significant (P=0.24).  The ratio of C-O (286.4 eV) to C-Si (284.3 eV) 
of PEG604-OH-PDMS (0.27 with experimental error) is nearly twice that of PEG5K-
OH-PDMS (0.16 with experimental error).  This indicates an increased grafting density 
[203] of PEG on OH-PDMS when PEG604 is used.  NAC-OH-PMDS presented with an 
increase in O 1s, N 2p, and S 2p and a decrease in Si 2p where NAC/EDC/NHS-OH-
PDMS had a significant increase in O 1s (P<0.05), but there was no indication of N 2p or 
S 2p.  The high-resolution C1s spectra revealed a decreased percentage of hydrocarbon 
peaks or C-Si peaks at 285.0 eV, an increased percentage of C-O or amine species, and 
an increase in H-O-C=O or amide species relative to the PDMS control (Table 9).  There 
was no significant difference between the C 1s spectra of the NAC modifications (P=0.72 
at 286.4 eV and P=0.81 at 288.6 eV).   
 
 
5.3.2 Modified surfaces decrease albumin and fibronectin adsorption 
 The inhibition of albumin adsorption in order from greatest to least was NAC > 
NAC/EDC/NHS > PEG5K > PEG604 (Figure 28).  These decreases in albumin 
adsorption from the PDMS control were significant when surfaces were treated with 
PEG5K (P<0.01), NAC (P<0.05), and NAC/EDC/NHS (P<0.01).  There was no 





samples (P=0.14), nor was there a significant difference in albumin adsorption between 
the NAC and NAC/EDC/NHS modification methods (P=1.00). 
 The inhibition of fibronectin adsorption in order from greatest to least was 
PEG604 > PEG5K > NAC/EDC/NHS > NAC (Figure 28).  PDMS had significantly more 
bound fibronectin than all other samples (P<0.01).  Compared with the OH-PDMS 
control, PEG604-OH-PDMS, PEG5K-OH-PDMS, and NAC/EDC/NHS-OH-PDMS all 
had significantly less fibronectin adsorption after the 20-hour exposure (P<0.05).  
Further, PEG604- and PEG5K-modified samples had significantly less fibronectin 
adsorption than the NAC-modified sample without EDC or NHS (P<0.05).  There was no 
significant difference in fibronectin adsorption between the PEG604- and PEG5K-
modified samples (P=1.00), but there was a significant increase in fibronectin adsorption 
on NAC-OH-PDMS as compared with NAC/EDC/NHS-OH-PDMS (P<0.05). 
 
 
5.3.3 Modified surfaces decrease macrophage and astrocyte binding 
 As determined by the average percent of DAPI intensity in the confocal images, 
the inhibition of macrophage adherence in order from greatest to least was PEG5K > 
NAC/EDC/NHS > PEG604 > NAC (Figure 29, Figure 30).  Using similar methods, the 
inhibition of astrocyte adherence in order of greatest to least was NAC > PEG5K > 
NAC/EDC/NHS > PEG604 (Figure 29, Figure 30).  That is, immobilized PEG604, 
PEG5K, NAC, and NAC/EDC/NHS reduced the average level of macrophage adhesion 
by 53%, 63%, 40%, and 58% (P<0.05 when comparing each case except NAC to 





72% (P<0.05 when comparing each case except PEG604 to PDMS), respectively.  The 
degree of macrophage adhesion seemed somewhat linearly dependent on contact angle 
and therefore surface wettability (R2 value = 0.742) whereas astrocyte adhesion seemed 
less linearly dependent (R2 value = 0.152) on surface wettability with the least amount of 
adhesion on NAC-OH-PDMS (with contact angle ~58°).  Compared with the PDMS 
control, all modifications significantly reduced macrophage (P<0.05) and astrocyte 
(P<0.05) adhesion, excluding the difference in macrophage adhesion between NAC and 
PDMS and the difference in astrocyte adhesion between PEG604 and PDMS.  The 
difference in macrophage adhesion between the PEG604 and PEG5K modifications was 
insignificant, as was the difference in astrocyte adhesion between the same samples.  The 
difference in macrophage attachment was insignificant between NAC and 




5.3.4 PEG modified PDMS 
 The significant difference in initial advancing water contact angle between the 
PEG-modified samples and PDMS together with XPS data showing increased surface C-
O on PEG-modified surfaces indicated that modified surfaces are rich with PEG.  Neither 
PEG604- nor PEG5K-modified PDMS contact angles returned to PDMS levels, but the 
PEG5K-modified PDMS appeared to maintain a lower contact angle over time.   The 





with PEG5K; however, this is expected because molecular weight and grafting density 
have been shown to be inversely proportional [203-204].  The difference in mean initial 
advancing and receding water contact angle between PEG604-OH-PDMS (7.2) and 
PEG5K-OH-PDMS (29.8) also alludes to less uniformity (and decreased grafting density) 
on PEG5K-modified PDMS.   
 Both PEG604-OH-PDMS and PEG5K-OH-PDMS decreased albumin adsorption 
compared with PDMS, by 55% and 90%, respectively, but this trend was only significant 
at the P.05 level when PEG5K-OH-PDMS was compared with PDMS.  The decrease in 
albumin adsorption on higher-molecular-weight PEG5K also corresponds to previously 
published results [204].  While albumin lacks motifs recognizable by host cells, enhanced 
adsorption may provide a gateway for bacterial colonization and biofilm formation, so an 
inhibition of albumin was preferred.  Fibronectin adsorption was decreased by 98% on 
both PEG samples compared with PDMS, and macrophage adhesion was significantly 
decreased on both PEG modifications.  However, there was a clear (but not significant) 
difference in the astrocyte response that correlated to the Fn response to both surfaces, 
suggesting that PEG5K inhibited  more  than PEG604.  We can speculate that the 
increase in molecular weight permitted increased chain mobility.  This increase in 
mobility may have been less conducive to astrocyte adhesion because astrocytes are 
particularly sensitive to mechanical stresses [165] or it may simply have been that the 
proinflammatory response of astrocytes on PEG5K is less than the proinflammatory 





 We conclude from the experiments with PEG that 1) PEG can be immobilized on 
oxidized PDMS and these modifications are relatively stable over time; 2) PEG-modified 
samples decrease initial protein adsorption and cell binding; and 3) PEG5K is preferential 
to PEG604 to inhibit inflammatory-derived adhesion in a fluidic and pulsatile 
environment.  Together with data indicating that PEG attenuates the acute 
macrophage/microglia response and the long-term astrocyte response [211], we speculate 
that PEG immobilization onto shunt catheters may provide an effective alternative to 




5.3.5 NAC modified PDMS 
 The advancing and receding water contact angle of NAC-modified PDMS with 
and without EDC and NHS was significantly lower than that of PDMS.  From low-
resolution XPS analysis and deconvolution of the C1s spectra, we can infer a presence of 
NAC on the surface of PDMS both by the existence of sulfur on NAC-OH-PDMS 
surfaces and by the enhanced C-O (at 286.4 eV) and O-C=O/amide species (at 288.6 eV) 
on both NAC-OH-PDMS and NAC/EDC/NHS-OH-PDMS.  The ratio of mean O-
C=O/amide species to C-Si can allude to the NAC grafting density on NAC-OH-PDMS 
(0.0526 with experimental error) and NAC/EDC/NHS-OH-PDMS (0.0418 with 
experimental error).  These data imply that the concentration of NAC is low and similar 





 Water contact angle measurements after a 30-day incubation in distilled water revealed 
that NAC-modified PDMS surfaces maintained significantly lower wettability (and increased 
hydrophilicity) compared with PDMS over time.  However, absorbance spectra revealed that 
NAC was released from NAC/EDC/NHS-OH-PDMS but not from NAC-OH-PDMS.  Assuming 
that NAC/EDC/NHS-OH-PDMS releases NAC despite maintenance of hydrophilicity over time, 
we can speculate that released NAC can non-specifically inhibit macrophage attachment upon 
release. It may be that released NAC can reduce the disulfide groups of adsorbed proteins and 
also of attaching cell integrins in a cell-type–dependent manner. However, a major concern 
related to the release of NAC is that prolonged attachment may be needed on shunt catheters that 
are implanted in patients for long periods of time.  
 Both methods of NAC immobilization on PDMS decreased albumin adsorption, 
fibronectin adsorption, and astrocyte adhesion significantly (P<0.05) compared with the 
PDMS control.  The relative degree of astrocyte adhesion on NAC modified surfaces also 
correlated to the relative Fn response to both surfaces.  Additionally, a trend indicated 
that NAC inhibited macrophage adhesion which was significant (P< 0.05) when PDMS 
was compared to NAC/EDC/NHS-OH-PDMS but not to NAC-OH-PDMS.  The 
mechanisms of NAC protein and cell inhibition on PDMS are still speculative and are 
probably multi-factorial. NAC bound or in solution can reduce bacterial growth in vitro 
[205].  After traumatic brain injury, NAC in solution has been shown to decrease 
cytokines present under proinflammatory conditions [212], decrease nuclear factor kappa 
B (NF-ҡB), interleukin-1 beta (IL-1β), tissue necrosis factor-alpha (TNF-α), and inter-





interferon-gamma (IFN-γ), and inducible nitric oxide synthase (iNOS) [213].  Whether 
NAC is released (in solution) or is bound to PDMS, it may modify acute protein 
adsorption and cell adhesion by hiding or modifying cell adhesion ligands.  In this study, 
the antibody used in immunofluorescent analysis of fibronectin targeted the cell adhesion 
ligand arginine–glycine–aspartic Acid (RGD).  The 75% mean reduction in RGD on 
NAC-OH-PDMS and 97% NAC/EDC/NHS-OH-PDMS surfaces compared with PDMS 
suggests that NAC may either passively inhibit adsorption because of its hydrophilic 
nature or actively cause a scission or change in protein folding that hides the cell 
adhesion ligands.  If this process is active, then chronic cell adhesion may also be 
inhibited because of the seemingly permanent changes in the adsorbed protein layer.  The 
effects of NAC on chronic adhesion have not been reported and are a source of future 
work.   
 We conclude from these experiments with  NAC that 1) NAC can be immobilized on 
oxidized PDMS where the hydrophilicity is stable over time but components of NAC are 
released from NAC/EDC/NHS-OH-PDMS; 2) NAC-modified samples decrease initial protein 
adsorption and cell binding; and 3) bound NAC (NAC-OH-PDMS) inhibits astrocyte binding 
more than surface-attached and releasing NAC (NAC/EDC/NHS-OH-PDMS), although these 
relationships are not significantly different.  Because a trend indicates that NAC/EDC/NHS-OH-
PDMS inhibits fibronectin adsorption and macrophage binding more than NAC-OH-PDMS, 
NAC/EDC/NHS-OH-PDMS may combat inflammatory cell obstruction in the short term more 





together with the enhanced inhibition of astrocyte adhesion on NAC-OH-PDMS may implicate 
NAC-OH-PDMS as the preferred NAC modification for long-term applicability. 
 PEG and NAC are two polymers that may inhibit protein adsorption, cell 
adhesion, and subsequent inflammatory cell obstruction of shunt catheters used in the 
treatment of hydrocephalus.  Both are hydrophilic, with an initial mean advancing water 
contact angle ranging from 33 to 65°.  While cell adhesion involves an array of factors, it 
is certainly dependent on surface chemistry as well as the conditions in which the catheter 
is implanted in vivo.  A trend in our previous work suggests that hydrophilic surfaces 
inhibit macrophage adhesion more so than astrocyte adhesion in the acute term depending 
on flow conditions that mimic those in the cerebral ventricles [210].  The data presented 
here support our previous work by suggesting that, while both macrophage and astrocyte 
adhesion is inhibited on hydrophilic surfaces, macrophage adhesion is more linearly 
dependent on surface wettability than is astrocyte adhesion.  Likely, the inhibition seen 
on PEG and NAC modified surfaces results from a combination of the surface 
wettability, the flow conditions, and the unique properties of PEG (e.g. steric hindrance) 
and NAC (e.g. disulfide reduction).   
 The only marketed hydrophilic surface coating used in the treatment of 
hydrocephalus, the poly(vinylpyrrolidone)-grafted catheter, was developed for increased 
lubricity but was shown to induce abscess formation in vivo [128].  Despite the success of 
other hydrophilic surface coatings in vivo, hydrophilic modifications have not been used 
to inhibit inflammatory adhesion in the treatment of hydrocephalus.  The extensive 





inhibit inflammatory cells that occlude catheters.  The unique properties of NAC also 
make it an interesting candidate to inhibit adhesion because of its novelty, 
biocompatibility, and bacterial inhibition.  Although PEG and NAC did have a dramatic 
effect on adsorption and binding compared with PDMS, the two binding strategies of 
PEG and the two of NAC used in this study did not produce any significant differences in 
acute albumin adsorption when they were compared with each other.   Both PEG 
modifications had significantly less surface-adsorbed fibronectin than did NAC-OH-
PDMS (P<0.05), but because macrophage and astrocyte adhesion was not significantly 
different between the PEG modifications and NAC-OH-PDMS, we cannot say that NAC-
OH-PDMS should be ruled out.  In fact, the data reveal a trend that suggests that NAC-
OH-PDMS decreased astrocyte adhesion more than the other modification strategies. 
 
5.5 Conclusions 
 In a bioreactor mimicking fluid flow within the cerebral ventricles, PDMS shunt 
tubing was modified with PEG and NAC to decrease macrophage and astrocyte adhesion 
that occludes catheters.  The inhibition of albumin adsorption in order of greatest to least 
was NAC > NAC/EDC/NHS > PEG5K > PEG604 and the inhibition of fibronectin 
adsorption in the same hierarchy was PEG604 > PEG5K > NAC/EDC/NHS > NAC.  The 
inhibition of macrophage adherence in order of greatest to least was PEG5K > 
NAC/EDC/NHS > PEG604 > NAC and the inhibition of astrocyte adherence in the same 
ordering system was NAC > PEG5K > NAC/EDC/NHS > PEG604.  Because of a 





compared with PDMS and on NAC/EDC/NHS-OH-PDMS compared with PDMS, these 
surface treatments have potential to inhibit macrophage and astrocyte dependent 




Figure 25 Water contact angle measurements on PDMS, PEG and NAC modified PDMS, 
and OH-PDMS shown in order of decreasing hydrophobicity from left to right 
immediatley proceeding modification.   As determined using a one-way ANOVA, 
decreases in advancing angles from PDMS are significant (P < 0.05) with every 
modification, and decreases in receding angles from PDMS are significant (P < 0.05) 
with every modification but PEG604-OH-PDMS (P = 0.13).   A sample size of 5 was 






Figure 26 Advancing water contact angle measurements over time on PEG604-OH-
PDMS (dotted line), PEG5K-OH-PDMS (dashed and dotted line), NAC-OH-PDMS 
(solid line), and NAC/EDC/NHS-OH-PDMS (dashed line).   No contact angle reached 
the advancing contact angle of the PDMScontrol (104.23 ± 1.02°) after 30 days.   All 
statistically significant differences were determined using a one-way ANOVA and are 






Figure 27  Mean absorbance at 260 nm over time to depict NAC release from PDMS over 
time.   There is a clear difference between release from NAC-OH-PDMS and 
NAC/EDC/NHS-OH-PDMS where NAC/EDC/NHS-OH-PDMS shows release of some 
or all NAC components from its surface.   All statistically significant differences were 





Table 8 Low resolution XPS atomic concentration results (percent ± STDV) 
 C 1s (%) O 1s(%) Si 2p(%) N 2p(%) S 2p(%) 
PDMS 48.9 ± 1.0 24.5 ± 0.6 26.7 ± 0.4 N/d N/d 
PEG604-OH-PDMS 43.8 ± 2.8 31.2 ± 1.2 25.0 ± 1.1 N/d N/d 
PEG5K-OH-PDMS 30.2 ± 4.0 42.0 ± 4.3 27.9 ± 0.6 N/d N/d 
NAC-OH-PDMS 51.2 ± 0.6 27.3 ± 0.2 17.1 ± 0.6 1.8 ± 0.3 2.6 ± 0.4 







Table 9 High resolution XPS Carbon Spectra (percent ± STDV)  
 284.3 eV  
(C-C/C-H/C-Si) 




PDMS 98.6 ± 2.5 0 ± 0 0 ± 0 
PEG604-OH-PDMS 78.6 ± 6.1 21.4 ± 6.1 0 ± 0 
PEG5K-OH-PDMS 80.5 ± 10.0 13.0 ± 6.1 0 ± 0 
NAC-OH-PDMS 83.6 ± 5.5 10.9 ± 1.9 4.4 ± 5.4 








Figure 28  Mean Fluorescent Intensities per square micron of FITC labeled albumin (A) 
and RITC labeled fibronectin (B).   Please note the difference in y-axis maxima.   
Asterisks denote significance of either P < 0.05 (*) or P < 0.01 (**) compared to PDMS.   
A minimum sample size of three was used for each group with two spots of analyses 






Figure 29 The average percentage of blue in dRGB space as determined by analysis of 
macrophage (A) and astrocyte (B) DAPI intensity.   Asterisks (*) denote significance of 






Figure 30 Macrophages (A–E) and astrocytes (F–J) bound to PDMS controls and 
modified PDMS.   Actin (red) and vinculin (green) were used to depict macrophages 
while GFAP (green) was used to define astrocytes.   DAPI (blue) was used to label the 






EFFECTS OF VENTRICULAR CATHETER ARCHITECTURE  
ON MACROPHAGE AND ASTROCYTE ADHESION4  
 
6.1 Introduction 
 Since 1955, the shunt system has been used to treat hydrocephalus by draining 
cerebrospinal fluid (CSF) from the cerebral ventricles, but its substantial failure rate has 
caused neurosurgeons and engineers to question its design.   The ventricular catheter of 
the shunt system is made of poly(dimethyl)siloxane (PDMS) and typically includes 32 
500-μm-diameter holes spaced approximately 500 μm apart in four rows [214].   These 
drainage holes are often occluded by parenchyma infiltration, choroid plexus tissue 
migration, and inflammatory cell accumulation [44, 49, 53, 108, 116], but manufacturers 
have only slightly altered the number of holes and their placement over the last 56 years 
[130].   There are no publicly available records indicating why the number of holes, the 
size of each hole, and the distance between holes was chosen.   Historically, the general 
consensus has been that the number and size of holes was chosen to facilitate adequate 
flow from the ventricular space, but recent studies have suggested that perhaps fewer 
holes are required to reach adequate CSF flow from the ventricles [116, 120].   
                                                 
4 Reprinted from Child's Nervous System, accepted manuscript, Harris, CA; McAllister JP  "Does Drainage 
Hole Size Influence Adhesion on Ventricular Catheters?" Copyright (2011), with permission from 







 Surprisingly, to our knowledge, there is only one study on ventricular catheters 
that has attempted to vary drainage hole size [131].   In 2003, Lin et al.  postulated that a 
graduated decrease in hole diameter from the catheter tip would alter the mass flow rate 
distribution and theoretically reduce the likelihood of occlusion [131], but the latter was 
not tested.   Importantly, modifying the size of the drainage holes changes the shear 
through the holes, a factor known to influence cell adhesion [102].   The current study 
expands upon previous work by observing whether adhesion of macrophages and 
astrocytes, two inflammatory cell types commonly found on obstructed catheters, is 
dependent on the size of the ventricular catheter drainage holes.   We hypothesized that 
increasing the hole size would decrease macrophage and astrocyte binding onto 
ventricular catheters. 
 
6.2 Materials and Methods  
6.2.1 Material design 
 To study the effect of the drainage hole size of the ventricular catheter, we 
designed PDMS samples with holes that varied from 282 to 975 μm in diameter.   The 
number of holes was calculated such that the bulk flow rate (0.25 mL/min or 
approximately 4.2 × 10-9 m3/s) and total hole surface area (6.3 × 10-6 m2) were equal 
across all samples.   The placement of the drainage holes across samples was designed to 
mimic the current clinical catheter by maintaining the distance between each hole 
(approximately 500 μm) and the number of hole rows (four).   Two fabrication techniques 





and hole production using photolithography and Bosch-like deep reactive ion etching 
(DRIE).   Table 10 shows sample group number assignments and their calculated 
parameters.   Shear stress has been calculated assuming that the volumetric flow rate 
through each hole and the hole diameter remain constant.   These shear stress values can 
be interpreted only as approximate values, however, because the volumetric flow rate 
through each hole has not been measured in this study and probably varies depending on 
(1) its proximity to the catheter tip [131], and (2) the measurement location within or 
immediately surrounding the hole. 
 
 
6.2.2 Punched holes in PDMS (groups one and two) 
 In an industrial setting, holes in current clinical catheters are fabricated in PDMS 
tubing with a sealed tip using a set of blunt-ended needles [215].   The needle set 
punctures each side of the catheter wall, creating holes.   Needles are removed, the 
catheter is rotated 90º, and the process is repeated such that four rows of holes are 
created, each with a 90º offset.   Holes in adjacent rows are also positioned in the interval 
between the neighboring holes. 
 Similarly, holes were mechanically punched in our laboratory using a set of blunt-
ended needles (Nordson EFD, Providence, RI).   Commercially available catheter tubing 
without pre-existing 500 µm holes (Medtronic, Inc, Goleda, CA) was cut into 4-cm 
lengths.   At one end of each catheter segment, 1 drop of PDMS Sylgard 184 (1 part 
catalyst: 10 parts base by weight, Dow Corning, Midland, MI) was injected and allowed 





the lumen, distilled water was injected into the opposite end.   Catheter segments were 
then individually placed in a stereotactic frame and punched with blunt-ended needles.   
The smallest holes (with average hole diameter of 282 μm) were punched into the PDMS 
tubing using a 32 gauge blunt needle, one of the smallest sizes manufactured.   To attain 
smaller size holes, wire punches were attempted.   Samples produced using wire punches 
produced less than optimal cutting profiles and were therefore discarded.   The PDMS 
surface area and the total hole surface area of each catheter segment equaled the PDMS 
surface area and total hole surface area of the clinical hardware (4.7 × 10-4 m2 and 6.3 × 
10-6 m2, respectively, Table 10).    
 
 
6.2.3 Lithographic discs (group three) 
 An alternative strategy to create holes in PDMS was attempted using a combined 
lithography/DRIE fabrication method.   First, the design pattern was drawn in AutoCAD 
2011 (Autodesk, Inc, San Rafael, CA) with 32 500-µm-diameter holes spaced 500 µm 
apart in four rows.   Using this design, a chromium-on-glass mask was fabricated with a 
±1.0-μm tolerance (Photo Sciences, St.  Torrance, CA).   Separately, 200-μm chromium 
layers were deposited on 4-inch-diameter silicon (Si) <100> wafers (p-type) obtained 
from the Nanofabrication Laboratory at the University of Utah.   These wafers were then 
placed on a 150°C hotplate for 5 min before spin-coating with thick positive photoresist 
(AZ® 9260, AZ Electronic Materials, Branchburg, NJ) at 1000 rpm for 1 min.   Wafers 
were allowed to sit untouched for 10 min after photoresist deposition to reduce the risk of 





3-cm inner-diameter rubber ring was placed around each mask pattern, and 
photolithography was performed using a hard contact aligner for 4 repetitive 17-s 
exposures set 30 s apart to transpose the mask pattern onto the chromium-coated wafer.   
A 25% concentration of AZ 400K Developer (AZ Electronic Materials) in water then 
removed excess photoresist (5 min) and a chromium etch exposed the negative space on 
the Si wafer (5-min exposure).     The wafer was washed with water, dried with nitrogen 
gas, and etched with oxygen plasma for 5 min.  A 2-step DRIE process was used to etch 
away negative space and attain vertical Si pillars.   A total of 650 SF6 and C4F8 cycles at a 
rate of 0.435 μm/cycle were used.   The wafer was again etched with oxygen plasma for 5 
min.   Release agent tridecafluoro-1,1,2,2,-tetrahydrooctyl1-1-trichlrosilane (13F) was 
vapor-deposited on the wafers under vacuum for 2 hours [216].   A surface profilometer 
(KLA-Tencor P-10 Profiler, Milpitas, CA) was used to measure the etch depth of the 
wafer.   The final PDMS sample was created by depositing 1 mL of degassed Sylgard 
184 (1 part catalyst to 14.3 parts base by weight, Dow Corning) onto the modified Si 
wafer.   This catalyst-to-base ratio was used to increase the ultimate tensile strength of the 
PDMS [217] to more closely represent commercial PDMS catheters with a thickness of 
approximately 1 mm.   Prior to curing, excess PDMS was removed using a 4-inch 
squeegee.   PDMS was cured for 10 min at 150°C [218] before it was lifted from the 
wafer.   The result was a reverse mold replication of the Si wafer columns to attain 
PDMS sheets with 500-μm holes.   The PDMS was punched into 13-mm-diameter discs 
to attain a PDMS surface area of 1.5 × 10-4 m2.    The thickness of the PDMS discs was 





6.2.4 Material surface analysis 
 Scanning electron microscopy (SEM) was performed using a Quanta 600 under 
high vacuum in the Surface Analysis Division of the Nanofabrication Laboratory at the 
University of Utah.  Images were acquired using a backscatter detector at both 40X and 
400X magnification.   An optical profilometer (Zygo Corporation, Middlefield, CT) was 
used to detect reflected light using a 40-μm bipolar (10-s) scan length and attain root 
mean square (RMS) average roughness values.   Samples were cut laterally such that the 
wall of the hole was exposed.   Fringes were nulled by adjusting the roll/pitch.   Values 
were averaged across the longitudinal plane of the hole wall to determine the effect of the 
cutting edge of the punch.   Because optimal profilometry was not ideal for Group 3 
lithographic discs (they were not impregnated with barium as Groups 1 and 2), atomic 
force microscopy was attempted to attain an RMS average roughness value of the hole 
wall.   The attempt failed because the force to acquire the image deformed the soft hole 
lumen, and thus average roughness data were not obtained for Group 3 samples.  
 
 
6.2.5 Macrophage and astrocyte adhesion assay 
 Mouse IC-21 peritoneal macrophages and rat primary astrocytes were attained 
and cultured using previously described methods [140, 210].   Briefly, macrophages were 
obtained from ATCC (SV-40 transformed peritoneal IC-21 macrophages, ATCC product 
number TIB-186) and cultured in RPMI-1640 medium with 25 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, Sigma, St.  Louis, MO), 1% penicillin-





Carlsbad, CA), and 10% fetal bovine serum (FBS, Sigma).   Astrocytes were obtained 
through an extraction and shake-off process and cultured in RPMI-1640 medium with 25 
mM HEPES, 1% penicillin-streptomycin, 1% GlutaMAX, and 10% FBS.   Both cultures 
were seeded in T-75 Culture Flasks (ISC Bioexpress, Kaysville, UT) and were split at 
80% confluence.   To mimic both the total protein (208.1 mg/L) and the albumin (155 
mg/L) concentration of cerebrospinal fluid, a subset of macrophages and astrocytes 
intended for analysis were immersed in a low concentration of albumin-rich medium 
(0.5% FBS with an albumin additive) for 24 hours before being detached and added to a 
cell adhesion assay.    
 
 
6.2.6 Cell detachment for passaging and experimental analysis 
 A 5-min exposure to 1X TrypLE Express (Invitrogen) caused macrophages and 
astrocytes to detach from cell culture flasks.   Once macrophages had been immersed in 
the enzyme solution for 5 min, physical dislodgement by striking the walls of the flasks 
sharply facilitated cell removal.   Viable cells were counted on a hemocytometer using 
the Trypan blue exclusion test and suspended in the low protein medium at a final cell 
suspension of 4.615 × 104 cells/mL (3 × 106 cells total).  The cellular solution was then 






6.2.7 Hydrocephalus Shunt Catheter Bioreactor   
 A previously published method established by our group to test adhesion on 
catheters [140]was manipulated in this study to measure macrophage and astrocyte 
adhesion after alterations in PDMS drainage hole size.   To mimic pulsatile flow 
conditions within the cerebral ventricles, the model uses a three-channel peristaltic pump 
(Watson-Marlow 401U/DM3, Cornwall, England).   In the published model, cells were 
propelled through the lumen of catheter tubing where adhesion was recorded.   In the 
current experiments, the system was slightly modified to encase a PDMS catheter or disc 
with drainage holes:  PDMS catheters (groups 1 and 2) were suspended in plastic 1-mL 
syringes with the cannula removed (BD, Franklin Lakes, NJ); PDMS discs (Group 3) 
were positioned in polytetrafluoroethylene (PTFE) 13-mm syringe filter holders 
(Swinney Syringe Holder, Sterlitech, Kent, WA).  From a suspension flask, the system 
propels a macrophage or astrocyte cell suspension toward the PDMS sample, through the 
holes of the sample, and out through either the lumen of the catheter or the back side of 
the disc (Figure 31).   A flow rate of 0.25 mL/min and a pulsation rate of 100 pulses/min 
were used in this study to imitate pulsatile, ventricular CSF flow under chronic 
hydrocephalus conditions [15].   Adhesion was measured in and around the drainage 
holes after a 20-hour exposure period.    
 
 
6.2.8 Fluorescent staining procedure  
 After the 20-hour exposure period, samples were removed and fixed with 4% 





fixative, polytetrafluoroethylene (PTFE) rings were used.   To identify the cell nuclei of 
cells fixed to the samples, immunofluorescence was employed.   Each sample was rinsed 
and stored overnight at 4°C in 0.1 M PBS.    For permeabilization, samples were 
incubated in 0.1% Triton X in 0.1 M PBS for 10 min.   Fifteen minutes of exposure to 
anhydrous methyl alcohol confirmed permeabilization of the macrophages.   Samples 
were stained with the nuclear dye 4',6-diamidino-2-phenylindole (DAPI) diluted from 1 
mg/mL stock to 1:1000 in 0.1 M PBS using established methods.    
 
 
6.2.9 Analysis of cell attachment  
 After fluorescent staining, a Leica microscope was used to obtain epifluorescent 
images of the exterior surface of the catheter.   Serial images were acquired from the 
catheter tip to the opposite end to (1) determine the total cell adhesion around all of the 
holes and (2) categorize data based on the position of the hole in relation to the catheter 
tip.  Catheters were then rotated approximately 90° and reimaged so that adhesion could 
be categorized based on the catheter orientation in the flow system (top, bottom, sides of 
catheter).   With all image acquisition, the camera settings were fixed to an exposure of 
702.5 ms.   A sample size of six catheters was used for each experimental group with 
analysis including examination of adhesion around every hole. 
 For analysis, DAPI channel images were loaded into ImageJ (National Institute of 
Health, Bethesda, MD) [219] and converted to 16-bit images before the contrast was 
enhanced with saturated pixels set at 0.5%.   The ellipse tool was used to construct 





equal across all groups.   The background was subtracted using a rolling ball radius of 25 
pixels.   Next, selected particles were analyzed where the threshold was adjusted to 
include only cell nuclei.   Advantages to this method are that only pertinent (in focus) cell 
nuclei were analyzed without background problems, information on the percent area 
covered by cell nuclei could be acquired directly rather than through inferences based on 
intensity, and data were not dependent on the identification of the hole edge.    
 To compare adhesion across groups with more focus on the area surrounding each 
hole, a second analysis technique was performed.   A custom software package was built 
to compute the average color in user-defined areas, including areas meant to distinguish 
holes, concentric rings surrounding the holes, and the image background.   The average 
blue component in digital Red-Green-Blue (dRGB) space was determined using the 
DAPI channel from the epifluorescent acquired images.   A normalized background was 
removed and data were reported as a percent from 0 to 255, with 255 representing 
brightest light emission.   Although analysis using nuclei area is preferred in this study 
because of the aforementioned advantages, this additional measurement provides cell 
density data in fixed distances from the hole edge.    
 
 
6.2.10 Statistical analyses 
 Acquired data were analyzed for normalcy using the Anderson-Darling normality 
test.   Parametric results were analyzed using either a two-tailed Student's t-test or a one-
way analysis of variance (ANOVA) with α = 0.05.   A post-hoc Scheffé test was 





Nonparametric data were evaluated using either a two-tailed Mann-Whitney U Test or the 
Kruskal-Wallis H Test with a confidence interval of 0.95 (α = 0.05).   Kruskal-Wallis H 
Tests were followed by unplanned comparison of mean rank tests using least significant 




 Light microscopy confirmed that holes were successfully created in all groups.   
The punching method in Groups 1 and 2 created a larger hole diameter at the punch entry 
site than the diameter of the punch exit site (visual tapering is noted in Figure 32).    
 The Si wafer prepared for PDMS cast molding of Group 3 lithographic discs can 
be seen in Figure 33.   DRIE processing caused a slight decrease in pillar diameter 
approaching the wafer surface of approximately 49 μm.   Pillar height with the 13F 
release agent was 279.20 ± 0.66 μm.   Subsequent PDMS discs had height (thickness) of 
267.77 ± 18.00 μm.   Because of the decrease in pillar diameter, the diameter of the 
Group 3 holes varied by approximately 50 μm. 
 
 
6.3.2 Comparison of fabrication methods 
 Fabrication methods across groups were compared by analyzing macroscopic 
(using SEM, Figure 32) and microscopic (using optical profilometry, Table 11) 
roughness as well as macrophage and astrocyte adhesion on 500-µm samples.   





was not apparent in Group 1 or Group 3 samples and was likely due to imperfections in 
the punch.   Analysis of the RMS roughness measurements between Groups 1 and 2 
revealed no significant difference in microscopic roughness.    
Adhesion results used to compare fabrication methods can be seen in Figure 34 
and Figure 35.   There was a significant difference (P < 0.05) in the degree of 
macrophage attachment on the Group 3 discs compared to both the Group 1 and 2 
catheters, but there was no significant difference in adhesion of macrophages on Group 1 
and 2 catheters.   There were no significant differences in total astrocyte adhesion.   
When adhesion was analyzed with respect to the distance from each hole edge, 
macrophage adhesion was significantly greater (P < 0.05) on the Group 3 discs than on 
the Group 1 or 2 catheters (at all distances away from the hole edge) but there was no 
significant difference in macrophage adhesion between Groups 1 and 2.   Astrocyte 
adhesion on Group 1 and 2 catheters appeared to increase with increasing distance away 
from the hole until it plateaued at approximately 150 µm whereas adhesion on the 
lithographic discs decreased around 100 µm and did not appear to follow the same trend 
with respect to distance away from the hole wall.   At all intervals away from the hole 
edge but 50 μm, astrocyte adhesion was significantly greater (P < 0.05) on Group 2 
catheters than on Group 1 or Group 3 samples.     
 
 
6.3.3 Comparison of hole size 
 Fabricated catheters used to analyze variance in hole size can be viewed in Figure 





were no statistically significant differences in RMS roughness values, except when 754-
μm samples were compared with 975-μm samples: 754-μm samples had a significantly 
smaller RMS value than did the 975-μm samples (P < 0.05).    
The average total area the macrophage nuclei occupied on the catheter followed a 
trend from least to most adherent as hole diameters decreased, 975 < 754 ≈ 500 < 282; 
the average total astrocyte adhesion from least to most adherent followed a trend as hole 
diameters changed, 975 < 500 < 754 < 282 (Figure 37, Figure 38).   A linear regression 
analysis with R2 values of 0.63 for macrophage adhesion and 0.84 for astrocyte adhesion 
implied a trend of decreasing adhesion with increasing hole diameter.   None of the 
differences in adhesion were significant, however, except for the differences in astrocyte 
adhesion on 282- and 754-μm samples compared with astrocyte adhesion on 975-μm 
samples (P < 0.05).   On 754-μm samples, the difference between macrophage and 
astrocyte attachment was significant (P < 0.05). 
Macrophage and astrocyte adhesion appeared to occur predominantly on the top 
of the catheter (remembering that the catheter was horizontally fixed in the flow system 
as seen in Figure 31).   On the top of the catheter, there were significantly more 
macrophage nuclei on 282-μm samples than on 500-, 754-, or 975-μm samples (P < 
0.05), but there was also a significant difference in macrophage adhesion between 754-
μm samples and 975-μm samples (P < 0.05, Figure 39).   Astrocyte adhesion on 975-μm 
samples was significantly less than astrocyte adhesion on 282- and 754-μm samples.   On 
the bottom of the catheter, there were no significant differences in macrophage adhesion 





μm samples.  Hole diameter did not create any significant differences in macrophage or 
astrocyte adhesion on the sides of the samples. 
There were no obvious trends suggesting that adhesion was dependent on the 
proximity of the hole to the catheter tip (Figure 40).   This finding was confirmed using a 
one-way ANOVA, which revealed no statistically significant differences in adhesion on 
282-, 500-, 754-, or 975-μm samples between the first, second, third, or fourth quarter of 
the holes.  Closest to the tip, there was a significant difference in adhesion on 282-μm 
samples compared with 500-μm samples (macrophages), 754-μm samples (astrocytes), 
and 975-μm samples (astrocytes and macrophages).   Adhesion in the latter half of the 
catheter (more distal to the catheter tip) was significantly greater on 282-μm samples 
compared with 500-, 754-, and 975-μm samples, independent of cell type.   
 
6.4 Discussion 
6.4.1 Fabrication method  
 Fabrication methods were varied among Groups 1–3 in an attempt to find a model 
method to analyze how modifications to hole size impact cell adhesion.   Group 2 
samples consisted of punched tubing with a sealed tip.   Holes were accurately placed 
when stereotactically guided.   The overall geometry of Group 2 samples was similar to 
that of Group 1 controls used clinically.   Fabrication was simple and created tapered 
holes with RMS roughness values that were not significantly different from RMS 
roughness values of Group 1 holes.   An important limitation to using Group 2 samples, 





Adhesion may be dependent on the visible grooves caused by imperfections in the punch.   
Future work should explore other fabrication methods to reduce this factor.   Perhaps the 
use of a sharp biopsy cutter would minimize these artifacts. 
 Lithography and DRIE were used to create a mold on which Group 3 PDMS discs 
could be cast.   These methods required the sample to be flat, although samples could 
conceivably be fixed around tubing after fabrication.   Fabrication was quite extensive 
and required labor-intensive trial and error.   Once complete, samples were not 
macroscopically rough, and hole walls were not tapered like those obtained with a 
mechanical punch.   Samples had a fixed distance between each hole with a much smaller 
deviation than Group 2 samples.   To create pillars in the Si mold that could withstand an 
injection and removal of PDMS, the pillars had to be fabricated with a minimal height (to 
decrease thinning of the pillar at the pillar base).   This inhibited the attainable thickness 
of the PDMS disc, which decreased the calculated ultimate tensile strength (data not 
shown).  The ultimate tensile strength was increased by altering the PDMS base: catalyst 
ratio, but the deformation of the PDMS under flow conditions may have been altered 
compared with deformation of thick PDMS catheter walls.   Additionally, a release agent 
was required to facilitate removal of the PDMS from the mold that may have added 
release agent residuals on the PDMS.   Finally, Group 3 samples were not impregnated 
with barium as was the shunt material for Groups 1 and 2. 
Extensive alternative strategies were tried in an attempt to fabricate Group 3 discs 
with a diameter less than 500 μm and with increased thickness.   Conventional 





Si wafer often tore the PDMS and/or broke the Si pillars.   To eliminate the shear caused 
by lifting the PDMS away from the Si wafer, we attempted to dissolve the Si wafer using 
potassium hydroxide (KOH), but despite attempts to alter the Si etching rate, the KOH 
attacked the PDMS, leaving it rougher and mesh-like.   The ratio of SF6 to C4F8 cycles in 
the DRIE process was also modified to decrease grass (surface roughness) and to attain 
more vertical walls, with little success.   Another strategy included the use of a gold 
release layer between the Si and the PDMS that would permit the release of the PDMS 
without damaging the micron-size holes.   This, too, tore the PDMS.   Attempts to 
increase the thickness of the PDMS layer caused the Si pillars to fracture more regularly, 
and a decrease in PDMS thickness often caused the PDMS to tear upon removal.   
Although there is still room for perfection in the final protocol, we were able to attain 
relatively thick PDMS samples with near-vertical hole walls for samples with hole 
diameter of greater than or equal to 500 μm. 
 Adhesion across fabrication types was compared by analyzing 500-μm hole 
diameter samples after macrophage and astrocyte exposure in the flow system.   There 
was a striking elevation of macrophages on Group 3 discs which was not evident when 
astrocyte adhesion was analyzed.  Perhaps this relationship was due to residual release 
agent on the PDMS surface; however, previous studies have suggested that macrophages 
bind to 13F (here used as a release agent) similarly to -OH functionalized surfaces [220].   
Therefore, this probably does not explain the difference in macrophage adhesion (Figure 
34), because data acquired in Chapter 4 suggest that macrophage adhesion tends to 





deviation in macrophage adhesion on Group 3 discs contributed to our decision to vary 
hole size using Group 2 samples. 
 After all pros and cons to both methods were analyzed, the Group 2 punching 
method was chosen to analyze how alterations in hole size influence macrophage and 
astrocyte adhesion.   Not only were the holes morphologically similar to those in the 
Group 1 controls, but the catheter geometry was analogous to that of the controls.   This 
created an environment in which appropriate flow vector fields would be applied to the 
sample and adhesion could be analyzed with dependencies on catheter orientation.    
Adhesion close to Group 1 holes also appeared to follow a pattern more similar to 
adhesion on Group 2 samples rather than to Group 3 samples. 
 
 
6.4.2 Drainage hole size 
 The degree of cell adhesion (from least to greatest) increased as hole size declined 
975 < 754 ≈ 500 < 282 (μm) for macrophages and 975 < 500 < 754 < 282 (μm) for 
astrocytes.   Adhesion was greatest around 282-μm holes, where there was a relatively 
high calculated shear stress of 0.0134 N/m2 (assuming an even flow distribution across 
holes).   Previous findings on leukocyte adhesion  suggest that increases in shear stress 
below 0.1 N/m2 will enhance adhesion [102], and our previous results on flow through 
catheter lumina indicate that an increase in flow (and therefore shear) at these levels 
increases astrocyte adhesion [140].   Although we did not test leukocyte adhesion and 
acknowledge that findings may be cell-type dependent, we can speculate that elevated 





with decreasing hole diameters.  In our opinion, the relatively small increase in average 
astrocyte adhesion on 754-μm samples compared with 500-μm samples is not sufficient 
to contradict this thinking. 
 Analysis of the data using linear regression suggested that the relationship 
between astrocyte adhesion and hole size was more linear than the relationship between 
macrophage adhesion and hole size.   It has been proposed that shear stress alters the 
kinetics of the receptor–ligand interactions that induce binding [103].   Perhaps the 
kinetics of macrophage receptor–ligand interactions are more threshold dependent than 
those of astrocytes, where elevated shear stress (albeit below 0.1 N/m2) does not 
exacerbate adhesion until shear exceeds a particular threshold (in this case between 
0.0134 and 0.0075 N/m2).   Another plausible explanation is that identical shear stresses 
may pull differently on macrophages than on astrocytes because of the difference in cell 
size.    
 In the only other study to date that has observed the effect of hole size, Lin et al.  
reported that flow and blockage are greatest in the holes farthest from the catheter tip and 
speculated that this was due to uneven flow distribution through the holes [131].   Our 
results implied no clear dependencies between adhesion and proximity to the catheter tip 
but rather a dependency on how the holes were oriented in the flow system.   This leads 
us to believe that one or more of the following are true: (1) flow distribution is not the 
only factor in adhesion and may be influenced by gravity; (2) obstruction that occurs 
distal to the catheter tip in vivo may be caused by other factors, including holes being 





chronic, multifaceted, obstruction.   Future work should explore these phenomena in 
more detail. 
 Lin et al.  expanded their work by varying hole sizes such that the diameter 
decreased distal to the catheter tip [131].   This was done in an effort to increase 
resistance to flow.   While the results of the study by Lin et al. suggested that flow could 
be changed by varying the hole size, we note that the proposed decrease in hole size 
would increase shear stress.   By using the flow distributions from the study by Lin et al., 
we calculated shear stress along the catheter.   This approach revealed that shear stress 
through all the adapted holes would be higher (0.0613 N/m2 most distal to the tip and 
0.0013 N/m2 most proximal to the tip) than through the holes of standard catheters 
(0.0361 N/m2 most distal to the tip and 0.0006 N/m2 most proximal to the tip).   If we 
assume that an increase in shear stress brought on by either an increase in flow rate [140] 
or a decrease in hole diameter (present study) increases adhesion, then a preferred 
catheter prototype should attempt to decrease shear stress through all of its holes.  A 975-
μm hole diameter produces the lowest shear stress of the tested samples (0.0039 N/m2 if 
flow is evenly distributed, 0.0078 N/m2 distal to the tip and 0.0008 N/m2 proximal to the 
tip if flow is distributed based on hole location).   Macrophage and astrocyte adhesion 
had a strong dependency on hole size (and presumably shear stress), and therefore these 
relationships must be considered in future studies.   From a practical perspective, if a 
continued effort indicates that a large hole size is preferred, the design must be such that 





 Although porous materials contain holes with diameters of a much smaller scale 
and often of a different morphological structure, we can draw some similar conclusions 
on hole size.   Previous work investigating porous materials implanted subcutaneously 
reveal that components of the foreign body reaction are dictated by the pore (hole) size 
[100-101].   A decreased pore size has been shown to increase mature collagenous tissue 
[101].   Similarly, astrocytes, which probably bind to the shunt catheter with the 
formation of the collagenous sheath, increase with decreasing hole size in this study.   
There may be no correlation in the mechanisms that cause these interactions, however, as 
the diameter of the holes and of the pores vary approximately 100-fold and the 
environment in which the materials are implanted is also considerably different.    
 An important limitation to this work is the degree of sample roughness.   Others 
have shown that adhesion is dependent on surface roughness [89], so it is likely that 
surface roughness played some role in macrophage and astrocyte adhesion in this study.   
Despite the fact that the only significant difference in microscopic RMS roughness values 
was between the 754- and 975-µm samples, we are currently investigating further 
alternative strategies to modify hole size independent of surface roughness. 
 
6.5 Conclusions 
 Two catheter drainage hole fabrication methods were attempted to manipulate the 
average hole diameter and relate it to macrophage and astrocyte adhesion.   Based on 
results of electron microscopy, optical profilometry, and analysis of macrophage and 





differences in hole size.   With this method, hole size can be manipulated easily and was 
found to directly impact cell adhesion around the holes of catheters.   The trend in overall 
adhesion from least to most adherent appeared to follow 975 < 754 ≈ 500 < 282-μm hole 
diameter for macrophages and 975 < 500 < 754 < 282 for astrocytes, perhaps because of 
a dependency on shear stress.   Further work must be performed, perhaps in a more 
chronic environment, to understand how these parameters alter obstruction.   
167 
 
Table 10 Sample group assignments 
Group 
Number 
Sample Type Hole  
Diameter  
(µm)  
Shear Stress  




1 (control) Industry Punched tube 500 0.0075 32 















3 Lithographic disc 500 0.0075 32 
 
  
                                                 






Figure 31  Diagram of the modified Hydrocephalus Shunt Catheter Bioreactor to measure 
the dependence of macrophage and astrocyte adhesion on the size of the drainage holes.  
A peristaltic pump was used to propel a cellular suspension from the solution reservoir 
(denoted "Spinner Flask"), through PDMS transport tubing (solid black line), through a 
point of flow restriction (small-diameter tubing to attain physiological flow and pulsation 
rates), through PDMS samples (PDMS catheters for Groups 1–2 or PDMS discs for 
Group 3), and back to the cellular solution reservoir.   Note that groups were run 







Figure 32  Scanning electron microscopy of 500-µm-diameter samples in each group 
revealed macroscopic grooves in the hole architecture in Group 2 (B) but not in Groups 1 
(A) or 3 (C).   Although RMS values were unattainable on the Group 3 samples, there 
was no statistically significant difference in microscopic RMS values in Groups 1 or 2.   
Groups 1 and 2 have apparent tapering of the hole walls, presumably because of the 
punch fabrication method.   Microfractures were not visible around the holes.   Scale bar 














Table 11 Comparison of fabrication methods ± STDV 
Group 
Number 




1 (control) 500 ± 2.4 1.12 ± 0.5 
2 281.7 ± 35.5 
460.0 ± 44.7  
753.8 ± 12.4 
975.05 ± 35.4 
1.10 ± 0.4 
0.93 ± 0.2 
0.88 ± 0.3 
1.48 ± 0.2 







Figure 34 Differences in fabrication methods were analyzed by measuring the total nuclei 
area.   The asterisks (*) represent a significant difference in adhesion compared to 






Figure 35 Differences in fabrication methods were analyzed by measuring the 
macrophage (A) and astrocyte (B) DAPI intensity around the holes.   All statistically 






Figure 36  Gross (A, D, G, J, M) and scanning electron (B, C, E, F, H, I, K, L, N, O) 
microscopy images depicting the total hole surface area and the surface morphology of 
Groups 1 and 2.   The distance between holes was fixed to 500 μm from the most exterior 
hole edge (489.6 ± 92.4 μm).   Roughness on a macroscopic scale appears large but 
relatively consistent.   Impregnated barium (white particulate) and imperfections (dark 
particulate) in the PDMS and on the PDMS surface can also be noted.   The scale bar in 
N represents 1000 μm at 40X (B, E, H, K, and N); the scale bar in O represents 100 μm at 






Figure 37 Adhesion of macrophages (A–D) and astrocytes (E–H) as a function of hole 
size.   Cells aggregated around the holes.   White circles denote the smallest diameter of 
each hole bearing in mind the tapering of the hole walls.   DAPI was used to label the 





   
Figure 38 Area occupied by cells around all holes.   Asterisks (*) denote a significant 
difference of the marked sample compared to astrocyte adhesion on 975 μm sample; 
alpha (α) represents a significant difference between macrophage and astrocyte 





      
Figure 39 Macrophage (A) and astrocyte (B) adhesion as a function of hole diameter and 
the orientation in which the catheter was positioned in the flow system.  In (A), the 
asterisks (*) denote significance of the marked sample compared to adhesion on 282 μm 
samples; in (B), asterisks represent a significant difference in adhesion compared with the 






Figure 40 Macrophage (A) and astrocyte (B) adhesion dependent on the proximity to the 
catheter tip.   The position relative to the tip is expressed as a percentage, where 0% 
represents adhesion closest to the tip and 100% denotes adhesion farthest from the tip.   
All statistically significant differences were determined using a one-way ANOVA and 






SUMMARY, CONCLUSIONS, AND FUTURE WORK 
 
 
7.1 In Vitro Flow Model for Macrophage and Astrocyte Adhesion 
Hydrocephalus is a debilitating disorder, in part because the most common 
treatment, shunting, has an extremely high failure rate.    From a detailed review of the 
literature, it becomes obvious that shunt failure is often correlated with an inflammatory 
response in which macrophages, glial tissue, and giant cells envelope the catheter exterior 
[48], migrate through the holes [44, 48], and/or invade the catheter lumen [44, 110].    
 Despite efforts to define causation, the mechanisms that influence the degree of 
inflammatory-derived shunt obstruction are not well understood.   In this dissertation an 
in vitro model was developed as a tool to help answer some of these questions in a 
controlled hypothesis-driven environment.   The model was meant to mimic adhesion of 
macrophages and astrocytes suspended in CSF in an acute 20 hour time period.   The 
model helped us to not only begin to understand key aspects of macrophage and astrocyte 
binding to silicone shunts, but it provided a test bed in which modifications to current 






7.2 The Effect of Mechanical Cues 
7.2.1 Pressure and Pulsation Frequency 
There appeared to be no significant impact on macrophage and astrocyte adhesion 
due to either alterations of pressure or pulsation rate by themselves in a physiological 
range.  We speculate that conditions of pressure might increase initial tethering of protein 
ligands and cells but are not enough to make a significant impact on overall adhesion 
after an acute exposure and may actually have an inhibitory effect depending on specific 
receptor-ligand interactions.   Pulsatile flow compared to oscillatory flow impacts 
cytoskeletal reorganization of cells and decreases nuclear factor kappa-light-chain-
enhancer of activated B cells (NFĸB, involved in inflammation) [163], but macrophage 




7.2.2 Shear stress and flow rate 
An obvious trend from this work suggests that adhesion of macrophages and 
astrocytes is dependent on calculated shear stress caused by either changes in total flow 
rate through the catheter lumen (Chapter 3) or in flux through each catheter hole as a 
result of changes in hole diameter (Chapter 6).     These findings coincide with 
implications from Lin et al. [131] who suggested that obstruction occurs where a majority 
of the flow occurs.   If we assume that adhesion is a function of measured shear stress just 
as adhesion appears to be dependent on calculated shear stress, we find that our data 





surpasses a certain level [102].   In our studies, data would suggest that adhesion 
generally increased with increasing shear stress with shear ranging from 0.0039 to 0.0134 
N/m2 (Chapter 3, Chapter 6) but not when a relatively large shear stress of 0.2409 N/m2 
was tested (Chapter 2, where the luminal diameter was decreased to increase shear).   
Another explanation for these  nonconforming data in Chapter 2 is the possibility that 
cells in a small diameter lumen with an arbitrary length behave differently than they do in 
a larger diameter lumen.   This is plausible since a recent study suggested that the 
reaction to a chronically implanted catheter is dependent on the length of the catheter 
[221].   
 
7.3 The Effect of Chemical Cues on Adhesion 
7.3.1 Protein concentration  
Generally, a higher protein concentration enhanced macrophage and astrocyte 
adhesion under fluidic conditions, but this trend was not significant.   Using PDMS 
catheters, extrapolation of these acute patterns may suggest that patients with a higher 
concentration of CSF protein may be more likely to have an inflammatory-related 
obstruction than patients with lower CSF protein levels, but this was not tested.    
 
 
7.3.2 Surface chemistry 
 Altering the surface chemistry with surface hydroxyl groups often decreased 
macrophage and astrocyte adhesion (Chapter 4).   These data suggest that, at least in the 





to question whether other hydrophilic surfaces inhibit adhesion in a similar environment.   
Chapter 5 results showed that macrophage and astrocyte adhesion was inhibited by the 
addition of polyethylene glycol (PEG) and N-Acetyl-L-Cysteine (NAC), two hydrophilic 
surface coatings that appeared to be relatively stable on PDMS catheters dependent on 
modification methods.   The extensive history and success of PEG-modified medical 
devices make PEG a logical candidate to inhibit inflammatory cells that occlude 
catheters.  The unique properties of NAC also make it an interesting candidate to inhibit 
adhesion because of its novelty, biocompatibility, and bacterial inhibition. 
 
7.4 Comparison of Macrophage and Astrocyte Attachment 
As referred to in Chapter 1, both macrophages and astrocytes are often 
components of inflammatory-derived shunt obstruction and therefore inhibition of both is 
likely to be essential to reduce shunt failure rate.   Macrophages and astrocytes appeared 
to respond differently to physiological mechanical and chemical cues.   Generally, 
mechanical cues appeared to have a more pronounced effect on astrocyte adhesion than 
macrophage adhesion, but mechanical cues seemed to alter macrophage morphology 
more than astrocyte morphology (Chapter 4).   Furthermore, astrocyte adhesion appeared 
to be greater than macrophage adhesion with a few exceptions related to shear (Chapter 
6).    Previous findings have shown that astrocytes translate mechanical signals into 
chemical messages [165] and that  monocyte interactions are weaker than those of other 
cell types under flow conditions [222].   Conceivably, if macrophage interactions are 





may appear more influenced by mechanical signals and may be greater than macrophage 
adhesion.   Perhaps under high and low shear stress extremes, the kinetics of macrophage 
receptor-ligand interactions vary so that adhesion surpasses astrocyte adhesion.    
 
7.5 The Impact of These Studies on Future Work 
A clear conclusion from these results is that a combination of mechanical and 
chemical cues promote or inhibit macrophage and astrocyte attachment to shunt systems.   
In this author’s opinion, flow and/or shear stress and surface chemistry are important 
mediators in inflammatory cell adhesion to ventricular catheters.   Perhaps if mechanical 
and chemical cues are modified by alterations in catheter architecture (for instance, 
increasing drainage hole diameter) and by long term surface modifications (for instance, 
using PEG surface coatings), a shunt system can be produced that is less likely to occlude 
from inflammatory cell adhesion and accumulation.   Of course, not all relationships 
could be tested in this work and future work in vitro and in vivo must validate these 
statements.   Others have proposed ways in which these relationships factor into 
adhesion.   For example, it has been suggested that adhesion to dialysis membranes is 
dependent on pore size as well as surface chemistry [223].   Similarly, results from 
Chapter 6 imply that adhesion appears to be dependent on hole size (since hole size 
changes shear stress through the holes) and Chapters 4 – 5 show a dependence on surface 
chemistry.   Results from Chapters 2 – 3 generally show similar patterns that imply 





 Certainly activation of macrophages and astrocytes in the cortical gray matter, in 
the periventricular white matter, in the CSF, or bound to the catheter itself may have a 
resounding effect on adhesion.   Activation of cells was beyond the scope of this study, 
but it remains an important aspect for understanding the mechanisms of obstruction, 
especially because gliosis is a well-known component of the pathophysiology of 
hydrocephalus.   Certainly flow, pressure, pulsation rate, protein concentration, cell 
concentration, and surface chemistry can manipulate soluble and insoluble mediators that 
may influence cell activity.   For instance, upregulation of the cytokine TNF-α [24] from 
hydrocephalic insult (perhaps due to changes in any of the above factors) and initial 
shunting could be a key regulator in macrophage and or astrocyte adhesion.   Certainly 
the activity of this and other proinflammatory cytokines and proteins have been shown to 
be key players in the foreign body response [23, 60, 64, 224].   These interactions must 
be studied in future work;  in the short term, the role of proinflammatory cytokines must 
be studied and manipulated in the flow system such that it properly mimics acute 
macrophage and astrocyte adhesion in vivo.   Proliferation of these cells may also play a 
key role in understanding obstruction. 
 The flow system developed, tested, used, and amended in this body of work was 
primarily meant to improve current in vitro testing with the long term objective being to 
develop a model in which univariable testing leads to shunt improvements.   While the 
system improved modeling compared to static in vitro systems and also was more 
applicable to hydrocephalus compared to other fluidic in vitro models, it is not without 





lacks systemic cues.   In future studies, results from the flow system should be compared 
to in vivo work.   Although Chapter 2 shows why each component of the system was 
used, a positive attribute to the system is that most of the components can be altered to fit 
user needs.   Adjusting the cell concentration and the types of cells are important future 
directions that may help us understand inflammatory derived shunt obstruction.    
The most dramatic difference in adhesion due to mechanical cues was an 
alteration in adhesion due to shear stress.   Results from this body of work can be used in 
future hypothesis driven studies to help identify the cause of inflammatory derived shunt 
obstruction.   In most cases, a decreased shear stress decreases initial macrophage and 
astrocyte binding.   These data can be expanded in numerous ways including future work 
that could relate these findings to CSF stagnancy at certain times of a patient’s life or 
during particular activities that may alter CSF production rate.   Results could further be 
expanded to understand why  devices used to continuously drain CSF (i.e., shunt 
catheters and valves) may be more susceptible to inflammatory cell adhesion than are 
devices inserted into the same cranial space that undergo less continuous flow and 
pulsatility (i.e., reservoirs). 
Results implicating a role of shear stress in macrophage and astrocyte adhesion 
can also be used in future work to develop strategies to inhibit obstruction.   While other 
studies including in vivo analysis to support these findings in the acute and chronic term 
are needed, we begin to speculate if pharmaceutical agents such as diuretic mannitol, 
which decreases CSF production and flow rate [225] and has been used to treat increased 





less conducive to macrophage and astrocyte adhesion.   Alternatively, these results can be 
used to manipulate the catheter architecture so that changes in hole size (Chapter 6), hole 
number (future work), or perhaps luminal diameter (future work) may influence adhesion 
because of inherent changes to shear stress. 
 Modifications to the surface chemistry can easily be expanded in the flow system 
and also in vivo to test other surface coatings and to test the long term applicability of the 
proposed NAC and PEG modifications.   There has been a trend over the last decade to 
tailor surfaces to actively target and dissuade cells from attaching [194].   These concepts 
can be employed in future studies for the improvement of shunt systems.   However, 
surface wettability is certainly not the only component of a surface that influences 
adhesion.   Future work should expand not only on surface wettability but on roughness 
and charge to correlate these results to those acquired with other medical devices.    
 Importantly, results acquired in this body of work may be used in future 
hypothesis driven studies to help inhibit inflammatory-derived obstruction.   Because the 
obstruction rate of shunt systems is incredibly high, modifications need to be tested with 
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